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Abstract
Background
Helicobacterpylori infection is a risk factor for gastric cancer, which 
is a major health issue worldwide. Gastric cancer has a poor prog-
nosis due to the unnoticeable progression of the disease and sur-
gery is the only available treatment in gastric cancer. Therefore, gas-
tric cancer patients would greatly benefit from identifying biomarker 
genes that would improve diagnostic and prognostic prediction 
and provide targets for molecular therapies. 
DNA copy number amplifications are the 
hallmarks of cancers in various anatomical 
locations. Mechanisms of amplification pre-
dict that DNA double-strand breaks occur at 
the margins of the amplified region. 
Objectives
The first objective of this thesis was to iden-
tify the genes that were differentially ex-
pressed in H.pylori infection as well as the 
transcription factors and signal transduc-
tion pathways that were associated with the 
gene expression changes. The second ob-
jective was to identify putative biomarker 
genes in gastric cancer with correlated ex-
pression and copy number, and the last ob-
jective was to characterize cancers based on 
DNA copy number amplifications.
Methods
DNA microarrays, an invitro model and re-
al-time polymerase chain reaction were used 
to measure gene expression changes in H.
pylori infected AGS cells. In order to identi-
fy the transcription factors and signal trans-
duction pathways that were activated after 
H. pylori infection, gene expression pro-
filing data from the H.pylori experiments 
and a bioinformatics approach accompa-
nied by experimental validation were used. 
Genome-wide expression and copy number 
microarray analysis of clinical gastric can-
cer samples and immunohistochemistry 
on tissue microarray were used to identify 
putative gastric cancer genes. Data mining 
and machine learning techniques were ap-
plied to study amplifications in a cross-sec-
tion of cancers.
Results
FOS and various stress response genes were 
regulated by H.pylori infection. H.pylori reg-
ulated genes were enriched in the chromo-
somal regions that are frequently changed 
in gastric cancer, suggesting that molecu-
lar pathways of gastric cancer and prema-
lignant H.pylori infection that induces gas-
tritis are interconnected. 16 transcription 
factors were identified as being associated 
with H.pylori infection induced changes in 
gene expression. NF-κB transcription fac-
tor and p50 and p65 subunits were verified 
using elecrophoretic mobility shift assays. 
ERBB2 and other genes located in 17q12-
q21 were found to be up-regulated in asso-
ciation with copy number amplification in 
gastric cancer. Cancers with similar cell type 
and origin clustered together based on the 
genomic localization of the amplifications. 
Cancer genes and large genes were co-local-
ized with amplified regions and fragile sites, 
telomeres, centromeres and light chromo-
some bands were enriched at the amplifica-
tion boundaries.
Conclusions
H.pylori activated transcription factors and 
signal transduction pathways function in 
cellular mechanisms that might be capable 
of promoting carcinogenesis of the stom-
ach. Intestinal and diffuse type gastric can-
cers showed distinct molecular genetic pro-
files. Integration of gene expression and 
copy number microarray data allowed the 
identification of genes that might be in-
volved in gastric carcinogenesis and have 
clinical relevance. Gene amplifications 
were demonstrated to be non-random ge-
nomic instabilities. Cell lineage, properties 
of precursor stem cells, tissue microenvi-
ronment and genomic map localization of 
specific oncogenes define the site specific-
ity of DNA amplifications, whereas labile 
genomic features define the structures of 
amplicons. These conclusions suggest that 
the definition of genomic changes in cancer 
is based on the interplay between the cancer 
cell and the tumor microenvironment. ❦
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Understanding the mechanisms underlying diseases 
furthers the development of treatments. Throughout the history 
of human illness, technological progress has played a central role 
in determining causes of diseases and laying the foundations for 
treatment (Table 1). A major trend in technological advancement in 
medicine has been that the causes of diseases are interrogated in in-
creasing resolution. Hippocrates defined diseases as having natural 
causes and treated patients with natural products to restore the 
humoral balance, whereas the development of microscope enabled 
the identification of bacteria as disease causing agents that lead 
to the discovery of antibiotics to treat infectious diseases. Know-
ledge about DNA structure (Watson and Crick, 1953) started a new 
molecular era in biology. Molecular biology is based on the theory 
of sequential information flow in living organisms, “The central 
dogma of molecular biology” (Crick, 1970; Crick, 1958). The dogma 
presents the information transfer events between three main bio-
molecules: DNA, RNA (nucleic acids) and proteins (Figure 1). 
Nucleic acids and proteins are biopolymers, which are made up 
of single building blocks. Nucleic acids are composed of nucleo-
tides (Adenine, Guanine, Cytosine, Urasil, 
Thymine; also referred to as A, G, C, U, T 
or bases) and proteins are made up of 20 
different amino acids. Genetic informa-
tion is translated from nucleotide sequence 
into amino acid sequence according 
to the genetic code, in which nucleotide 
codons (words of three nucleotides or 
triplets) correspond to specific amino acids. 
The genetic information is stored and distri- 
buted in DNA, transmitted via RNA and 
to be put into practice by proteins. 
The information may be transferred 
from one biopolymer compartment to 
another according to the rules formulated 
by Francis Crick (Crick, 1970; Crick, 1958). 
General transfer operations, which occur in 
Introduction
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Table 1. 
Biomedical	timeline.	
Cancer	related	inventions	are	marked	red.
most of the living organisms, include repli- 
cation, transcription and translation. Repli- 
cation is a process where DNA sequence is 
copied. DNA sequence is usually in double- 
strand form, and in most cases this feature 
is preserved in replication. In transcription, 
single-strand RNA is synthesized using 
a DNA template. RNA code is comple-
mentary to DNA template, given that T is 
replaced with U. In turn, RNA sequence is 
used as a template in translation, where spe-
cific three nucleotide triplets, codons, corres- 
pond to specific amino acids. In addition, 
there are some information transfers that 
only occur in abnormal conditions, labora-
tory experiments or in some viruses.
The development of molecular biolo-
gy techniques were of remarkable conse-
quence in cancer research, since cancer is 
a disease where DNA sequence informa-
tion is erroneously encoded. According to 
the fundamentals of information flow in 
eukaryotic cells, DNA sequence errors (also 
referred to as mutations) are transferred to 
 
Introduction
21
Genomic and functional 
profiling of gastric cancer
Figure 1 
Central dogma in molecular biology
In	living	organisms,	genetic	information	flows	through	DNA,	RNA	and	proteins.	A)	An	illustration	of	the	
information	transfer	events	in	eukaryotic	cells.	DNA	doubles	in	replication	in	semi	conservative	manner	
as	both	of	the	complementary	strands	serve	as	a	template	for	newly	synthesized	DNA.	In	transcription,	
the	DNA	code	is	reformatted	to	the	RNA	code.	Mature	messenger	RNA	(mRNA)	translocates	out	from	
the	nucleus	and	translation	takes	place	in	the	ribosomes	in	the	cytosol.	The	transfer	RNA	(tRNA)	joins	the	
amino	acids	(building	blocks	of	proteins)	according	to	the	information	encoded	in	the	mRNA	sequence.	
B)	Schematic	overview	of	the	information	transfer	events.	Biological	data	flows	through	general	informa-
tion	transfer	events	in	majority	of	living	organisms.	In	special	situations,	additional	information	trans-
fer	events	exist.	The	central	dogma	states	that	once	the	information	is	translated	into	protein	it	can	not	go	
back	to	the	nucleic	acid	code.	Figure	produced	after	www.genome.gov/glossary.cfm	with	permission	from	
the	National	Human	Genome	Research	Institute.
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RNA in transcription and to daughter cells 
through DNA replication during cell divi-
sion. Altered RNA sequence translates into 
altered amino acid sequence, and the abnor-
mal protein structure has an altered func-
tion in the cell. Eventually, DNA mutation 
encoded perturbations in protein function 
lead to the transformation of a normal cell 
to a cancer cell. In healthy tissue, cell death 
and renewal are balanced and controlled. 
Tight surveillance of cell division and dis-
posal enable the proper cell function and 
number in tissues and organs. In cancer 
cells, the mechanisms that execute the sur-
veillance of cell existence have been turned 
off, which leads to uncontrolled growth, 
limitless replication, acquisition of nutri-
ents and expansion. Hanahan and Wein-
berg have defined the physiologic changes, 
six hallmarks, that characterize the cancer 
cell phenotype (Hanahan and Weinberg, 
2000). Uncontrolled growth requires that 22
A) B)
CCGGTC CGTACGTA
CCGGTC CGTACGTG
CCGGTC CGTACGTA
CCGGTC CGTACGT..
CCGGTC CGTACGTA
CCGGTC CGTACGTAG
Substitution
Deletion
Insertion
Figure 2
Mutations in cancer
A)	Chromosomal	rearrangements.	Image	is	obtained	from	www.genome.gov/
glossary.cfm	with	permission	from	the	National	Human	Genome	Research	
Institute	and	B)	point	mutations.
A) B)Deletion 	Duplication Inversion
Insertion
Chromosome	20
Chromosome	20
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cancer cells are (1) independent of growth 
supporting signaling and (2) notwithstand-
ing growth restraints. Cancer cells acquire 
limitless replication potential by becom-
ing (3) immune to programmed cell death 
(apoptosis) and (4) free from natural repli-
cation restraints (telomere shortening). In 
order to proliferate cancer cells need nutri- 
ents. Thereby, (5) activation of neovascu-
larization and vascular maintenance are 
required for tumor growth. Because of this, 
cancer cells must possess the capability to 
promote angiogenesis, generation of new 
blood vessels into solid tumor mass. Malig-
nant capacity is achieved when cancer cells 
(6) lose the control of their primary anatom-
ical location and begin tissue invasion and 
to metastasize to distant sites.
Cancer cells acquire the hallmarks of can-
cer and the capacity to grow unsupervised 
when mutations change the function of can-
cer genes (Hanahan and Weinberg, 2000). 
Cancer genes are originally normal human 
genes that function in cell growth, replica-
tion, energy metabolism and microenviron-
ment modeling. By definition, when mutated, 
they are capable of promoting and partici- 
pating in cancerous cell growth. Cancer 
genes may be activated by gain-of-function 
mutations (oncogenes) and silenced by loss-
of-function mutations (tumor suppressor 
genes). Even when inherited germ line muta- 
tions and their induced cancer syndromes 
are known to promote the emergence of 
a subset of cancers, mutations of cancer 
genes are usually somatic, sporadic changes 
in DNA sequence of non-gamete cells. The 
mechanisms that induce genomic changes 
include chromosomal rearrangements (Al-
bertson et al., 2003) and nucleotide point 
mutations (Figure 2). These mutations 
can cause both, gain and loss of function 
of genes, depending on the end point. The 
point mutations that alter DNA sequence 
at a specific nucleotide can activate an 
 
Introduction
oncogene, if it encodes a change in oncop-
rotein that renders it immune to expression 
regulation or whether it has an increased 
activity. Nucleotide point mutations can 
alter the reading frame in the gene or 
introduce a new stop codon that destroys the 
original protein product. Structural chro-
mosomal rearrangements, such as trans- 
location and inversion, can produce gene 
fusions that activate oncogenes or break and 
suppress function of genes. Inversion is a 
situation in which a genomic segment flips 
around to another direction. In addition to 
translocations, fusion genes can emerge also 
when a genomic sequence is deleted and the 
ends of a broken chromosome are rejoined. 
Translocation refers to a situation where 
genetic materials from two different chro-
mosomes are joined and form a novel geno-
type at the site of the junction. Translocation 
can be either balanced, when no DNA mate-
rial is lost and no additional chromosomal 
fragments are present in the cell, or unbal-
anced, if genomic material is lost from the 
cell during the rearrangement. Alterations 
that change the DNA copy number are fre-
quently observed in a variety of human can-
cers (Mitelman et al., 1994). Normal dip-
loid human genome contains two copies 
of each gene and alterations in gene copy 
number are one of the main mechanisms 
that activate oncogenes. 
Previously, the treatment of cancer has re-
lied on surgery and radiation therapies as 
well as on chemotherapies. Although they 
are useful in treating locally occurring tu-
mors, these techniques are ineffective 
against tumors that grow in unapproachable 
locations and metastasize to distant sites. It 
has become evitable that targeted therapies 
are needed to treat wide-spread disease. Ad-
vances in molecular biology provided new 
means to determine mutated genes and at-
tack cancer cells by targeting the oncopro-
teins that they encode. Major breakthroughs 
have been established using molecular 
biology techniques in exploring genetic 
basis of cancer, such as identification of TP53 
and RB tumor suppressor genes and mole-
cular changes in chronic myeloid leukemia 
(CML). The use of molecular targeted drugs 
in CML is one of the greatest successes 
in the treatment of cancer. CML is charac-
terized by a chromosomal rearrangement, 
Philadelphia chromosome, which is formed 
in translocation between chromosomes 9 
and 22. In the site of the translocation a 
fusion of the BCR and ABL genes takes 
place. Gene fusion causes increased acti-
vation of the ABL tyrosine kinase. Imatinib 
mesylate (also known as Gleevec® or 
Clivec®) is a small molecule inhibitor of 
the kinase activity of ABL and in 2001 it was 
approved as a therapeutic agent for the treat-
ment of CML. In addition, Imatinib mesylate 
has been successfully used as a therapeu-
tic agent in the treatment of gastrointestinal 
stromal tumor, a mesenchymal tumor char-
acterized by KIT positivity, as, besides ABL, 
Imatinib mesylate has been shown to inhibit 
the KIT tyrosine kinase activity (Miettinen 
and Lasota, 2006). 
In spite of the great improvements that 
have been made in order to unreveal the 
molecular backgrounds of cancer and of the 
fact that some cancers with specific genetic 
changes can be treated using target drugs, 
most of the cancers still remain untreatable. 
The majority of the most lethal forms of can-
cer is multifactorial, and forms a heteroge-
neous set of diseases that do not have spe-
cific mutations that could be targeted with 
drugs. Instead of one specific target there 
might be diverse sets of genes that are per-
turbed and are causing disease. Traditional 
molecular biology provides a reductionist 
approach that tries to resolve the complexity 
24
Figure 3 
Principles	of	a	microarray	experiment
From	www.genome.gov/glossary.cfm.	Image	is	used	with	permission	
from	the	National	Human	Genome	Research	Institute.
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in living organisms by studying individual 
molecular objects separately. It is not pos-
sible to identify groups of disease genes 
using traditional molecular biology tech-
niques, since it is difficult to be sure wheth-
er the objects of research are the right ones 
or whether there are combinatorial effects 
between the biological components. To cir-
cumvent these limitations, a second major 
technological trend in biomedicine has 
been to increase the throughput of the 
experimental measurements. In this perspec- 
tive, comparative genomic hybridization 
(CGH) (Kallioniemi et al., 1992) had an 
unprecedented impact on the field of can-
cer research because it introduced new tech-
nological concepts that allowed up-scaling 
of the measurement capacity. Firstly, CGH 
was a genome-wide technology for high-
throughput examination of the DNA copy 
number. Secondly, in CGH, a hybridization 
probe was placed on a solid support and 
samples were labeled using fluorescent 
dyes. Thirdly, CGH was based on measur-
ing relative changes in fluorescence inten-
sities between the test sample and the refe- 
rence sample. Further development of 
genome-wide technologies has been largely 
relying on these principles. 
Another true milestone in the develop-
ment of biomedical technologies was the 
sequencing of the human genome (Lander 
et al., 2001; Venter et al., 2001). In addi-
tion to revealing the organisms’ building in-
structions, a detailed knowledge of genome 
sequences has facilitated the genome-wide 
analysis of gene expression (RNA synthesis) 
patterns in the field of functional genomics 
using DNA microarrays (DeRisi et al., 1996; 
Schena et al., 1995). Whereas in CGH, in 
which metaphase chromosomes were used 
as probes, DNA microarrays consist of col-
lections of single-strand DNA probes spot-
ted on a glass surface (Monni et al., 2002). 
Specific probes with sequences that are com-
plementary to different genomic counter-
parts, genes or genomic map locations, can 
be produced. Oligonucleotide probes from 
20 to 60 nucleotides (Agilent Technologies 
and Affymetrix, Palo Alto, Ca) can be synthe-
sized and cDNA probes were collected from 
DNA libraries (Monni et al., 2002). Micro-
array experiment is based on the hybridiza-
tion of complementary, single-strand DNA 
fragments and detection is made possible by 
labeling the sample using fluorescent dyes 
(Figure 3). Microarray experiments are semi-
quantitative as the sample is co-hybridized 
with a reference, and changes in fluores-
cence intensity ratios are measured. Either 
DNA or RNA may be used as a sample in 
microarray experiment, although, RNA has 
to be reverse-transcribed to complementary 
DNA (cDNA) using specific viral enzymes 
(Monni et al., 2002). The amount of RNA 
in a given condition is a measure for gene 
expression and functionality. While post-
transcriptional regulation of gene expres-
sion exists, the intensity of transcription is 
one of the main regulators of gene function. 
Similarly, the amount of DNA corresponds 
to the gene copy number. In addition to the 
basic research, microarray technologies are 
starting to penetrate the clinical practice as 
products like MammaPrint®, the Food and 
Drug Administration of the United States 
approved diagnostic test, which uses measure- 
ments of some 70 genes to predict the 
metastatic behavior of breast tumors, are 
being developed (Buyse et al., 2006). 
Genome-wide technologies have exponen-
tially increased the amount of quantita-
tive data produced by biomedical research. 
Large-scale datasets can not be processed 
using human resources, but the develop-
ment of microprocessor and propagation 
of computers have allowed high-through-
put analysis of genome-wide biomedical 
data. There are databases for storing and 
managing genome-wide datasets (Edgar et 
al., 2002) and genomic information (Flicek 
et al., 2008) as well as bioinformatics methods 
are needed in order to analyze genome-wide 
measurements and to interpret multifactori-
al biological phenomena. ❦25
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Gastric cancer is a major health issue in Finland and world-
wide. Close to one million new gastric cancer cases, 9% of all can-
cers, were diagnosed in the year 2002 alone (Ferlay et al., 2004). 
As an example of the scope of the problem, gastric cancer was the 
second most common cause of cancer-related death. In Finland, 
gastric cancer ranked sixth in mortality with close to 600 annu-
al deaths and eighth in prevalence (over 700 new cases diagnosed 
yearly). Gastric cancer is the fourth most common cancer (after 
lung, breast, and colorectal cancers) (Ferlay et al., 2004). The high-
est incidence areas are Asia, Eastern Europe and the Andean region 
in South America, whereas low rates are found in America, North-
ern Europe, South-East Asia and Africa (Figure 4). Incidence and 
risk in high risk areas are usually as much as ten times larger than 
in low risk areas (Figure 4 and Table 2). Gastric cancer is more fre-
quent in males than in females, and usually affects elderly, as 75% 
of gastric cancer patients are over 54 years old (Figure 5).
There are two distinct subtypes of gastric cancer, intestinal and 
diffuse (Lauren, 1965). Undifferentiated diffuse type is character-
ized by non-cohesive and scattered cancer cells that grow by in-
filtrating deep into the stroma (Werner et al., 2001). Intestinal 
gastric cancer forms distinguishable and distorted glandular struc-
tures and grows by expansion (Werner et al., 2001). The Intesti-
nal type gastric cancer progresses through 
sequence of premalignant lesions (Figure 
6). Generally, diffuse type gastric cancer is 
not characterized by stepwise progression 
and intermediate steps but there is evi- 
dence that premalignant polyps are found 
in gastric crypts preceding hereditary dif-
fuse type gastric cancer (Oliveira et al., 
2005). Moreover, premalignant stages, 
chronic gastritis, atrophy and achlorhydric 
stomach and intestinal metaplasia, are risk 
factors in the pathogenesis of intestinal 
gastric cancer, while simple inflammato-
ry stress is associated with the diffuse type 
(Fenoglio-Preiser et al., 2000). The in-
testinal type gastric cancer affects older pa-
tients and it has slightly better prognosis 
than the diffuse type, which is more preva-
lent in younger patients (Fenoglio-Preiser 
et al., 2000). The intestinal type is more 
common in males than in females but simi-
lar gender bias is not observed in the diffuse 
type (Teh and Lee, 1987). Hereditary gastric 
cancer, associated with CDH1 mutations, 27
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manifests solely as diffuse type (Oliveira 
et al., 2006). All in all, different subtypes 
of gastric cancer have both biological and 
clinical distinctive features. 
Gastric cancer is an aggressive disease, 
and 5-year survival rates are only 10 to 30% 
(Green et al., 2002; Harrison et al., 
1998; Msika et al., 2000). The high mor-
tality rate of gastric cancer is explained by 
the fact that the early stages of gastric can-
cer are often asymptomatic and left unde-
tected. Thus, the majority of the diagnosed 
tumors in the stomach are malignant gas-
tric adenocarcinomas (Schwartz, 1996), 
and the clinical panorama of gastric cancer 
is dominated by tumors that invade lymph 
nodes and metastasize to distant locations 
(Hundahl et al., 2000).  The treatment 
of gastric cancer is restricted to gastrecto-
my (removal of the stomach), endoscopical 
surgery and lymphadenectomy (removal of 
lymph nodes).  Patients may therefore great-
ly benefit from predictive diagnosis based 
on the biomarkers that would guide clinical 
cancer management and from the adminis-
tration of targeted therapies.
Molecular markers for diagnostic and 
prognostic purposes as well as therapeutic 
targets are required in the treatment of gas-
tric cancer, because of the inconspicuous pro-
gression of the disease and its poor response 
to therapy in later stages. Furthermore, gas-
tric cancer comprises two different subtypes, 
intestinal and diffuse, that may have differ-
ent molecular properties and treatment re-
quirements. Several epigenetic (methyla-
tion), genetic (polymorphisms, mutations, 
amplifications and deletions) and function-
Gastric cancer incidence in males (per 100 000)
Gastric cancer incidence in males (per 100 000)
Figure 4 
Demographic	distribution	of	gatric	cancer	incidence
Gastric	cancer	incidence	is	shown	in	males	(per	100	000).
Figure	was	produced	using	Globocan	2002	software	(Ferlay et al., 2004)
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al (overexpression) alterations have been as-
sociated with gastric carcinogenesis, trans-
formation and cancer progression (Table 3). 
Even when many genetic and epigenetic de-
fects have been identified in gastric cancer, 
molecular biology based applications in clini- 
cal practice used to treat gastric cancer are 
still few.
Diet shows the most significant associa-
tion with gastric cancer in many epidemio-
logical studies (Fenoglio-Preiser et al., 
2000). Alcohol consumption and smoking 
are the main risk factors for gastric cancer 
(Salaspuro, 2003). Heavy alcohol usage is 
particularly associated with gastric cancer in 
Asian individuals, because of the frequent 
genetic inability to detoxify acetaldehyde, 
ethanol metabolite. Acetaldehyde has been 
experimentally shown to be mutagenic and 
carcinogenic. Moreover, the microbes in the 
stomach are able to endogenously produce 
acetaldehyde from ethanol. A high concen-
tration of acetaldehyde in the stomach is as-
sociated with pathogenesis of gastric can-
cer. Sufficient consumption of fresh fruits 
and vegetables lowers the risk of gastric can-
cer, whereas intake of salt, smoked or pick-
led food and chili peppers increases the risk 
of gastric carcinogenesis (Fenoglio-Prei-
ser et al., 2000). The protective effect of 
fruits and vegetables is believed to be as-
sociated with the antioxidant activity found 
in these foods. Gastric cancer risk elevates 
after bile reflux which causes gastric irri-
tation because of the bile fluids. Nonethe-
less, the most significant development in 
the etiology of gastric adenocarcinoma was 
when H.pylori infection was identified as 
a causative factor in gastric carcinogene-
sis. While diet is considered to be associ-
ated with the majority of cancers, H.pylo-
ri infection seems to be specific to gastric 
cancer. Because of the strong epidemiolog-
ical evidence H.pylori infection was identi-
fied as a risk factor for gastric cancer by the 
International Agency for Research on Can-
cer (IARC, 1994).
H. pylori infection in gastric  
cancer pathogenesis
The 2005 Nobel Prize winners for Medi-
cine, Barry Marshall and Robin Warren, 
demonstrated in 1982 that H.pylori infec-
tion causes stomach inflammation as well 
as duodenal and gastric ulcers (Marshall 
and Warren, 1984). After the observations 
made by Marshall and Warren, H.pylori in-
fection, and subsequent atrophic gastritis, 
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Table 2
Population-based	differences	in		
the	incidence	and	risk	of	gastric	cancer.	
Population	 Gender	 Crude	rate	 Cases
Finland	 Male	 15,3	 387
Finland	 Female	 12,3	 326
Japan	 Male	 118,6	 73	785
Japan	 Female	 55,4	 35	994
Crude	rate;	cases	per	100	000
700	000
600	000
500	000
400	000
300	000
200	000
100	000
0
Age	group
In
ci
de
nc
e
0	–14 15	–44 45	–54 55	–64 65	+ All	ages
▪	Female		▪	Male
Figure 5
Age	distribution	of	gastric	cancer	patients
Worldwide	incidence	of	gastric	cancer.		
Data	was	collected	using	Globocan	2002	software	
(Ferlay et al., 2004).
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Gene Gene	function Role	in	cancer Changes Reference
APC wnt/β-catenin	and	
TGFβ-pathways
Tumor	suppressor	
gene
Mutations (Fang et al., 2002)
AURKA Cell	cycle,	mitosis Progression Functional		
polymorphism
(Ju et al., 2006;  
Kamada et al., 2004)
BTRC wnt/β-catenin		
pathway
Mutations (Kim et al., 2007)
CCND1 Cell	cycle High	levels	are		
associated	with	alco-
hol	consumption
Amplified	and		
overexpressed,		
polymorphisms
(Bizari et al., 2006)
CCNE1 Cell	cycle Amplification	and	
overexpression
(Varis et al., 2003)
CDH1 TGFβ-pathway Hereditary	diffuse	
gastric	cancer
Mutations (PeeK and reddy, 
2007)
CDKN2A Cell	cycle Inactivation	by	
methylation	or	LOH
(zhang et al., 2003; 
zhao et al., 2007)
CTNNB1 wnt/β-catenin/
TGFβ-pathway,		
cell	cycle
Associated	with		
invasive	and		
aggressive	disease
Mutations (Cheng et al., 2005)
RHOBTB2 Tumor	suppressor	
gene	that	has	growth	
inhibitory	function
Mutations	and	LOH (Cho et al., 2007a)
EGFR Transmembrane		
receptor	protein		
kinase
Associated	with	
poor	survival,	target	
for	tyrosine	kinase	
inhibitors
Increased		
expression
(galizia et al., 2007)
ERBB2 Transmembrane		
receptor	protein		
kinase
Target	for	inhibitors Mutations,		
amplification
(lee et al., 2006)
GAST Gastrin	hormone,	
mitogen
Associated	with		
intestinal		
metaplasia	and		
gastric	carcinoma
Amplified	and		
elevated	expression
(doCKray, 2004)
HRAS Signal	transduction Overexpression (Kim et al., 2000)
KRAS Signal	transduction Mutations (lee et al., 2006)
MET Tyrosine	kinase Activated	in	GC	and	
intestinal		
metaplasia,	induces	
proliferation
Differential		
expression
(inoue et al., 2004; 
tang et al., 2004)
NRAS Membrane	protein Mutation (sasaKi et al., 2004)
Table 3
Gastric	cancer	associated	genes.	LOH;	loss	of	heterozygocity,	GC;	gastric	cancer.
Gene Gene	function Role	in	cancer Changes Reference
PIK3CA PTEN	pathway Mutations,		
up-regulation
(li et al., 2005a)
PPP1R1B Kinase	or	phospha-
tase	inhibitor,	regu-
lation	of	apoptosis
Amplified	and		
overexpressed
(BelKhiri et al., 2005; 
Varis et al., 2004)
PTEN Cell	cycle Tumor	suppressor	
gene
Mutations,		
down-regulation
(li et al., 2005B)
PTGS2 prostaglandin	syn-
thesis,	inflamma-
tion,	mitogenesis
Target	for	inhibitor,	
prognostic	factor
Polymorphisms,	
over-expression
Numerous
PTPN11 Membrane	protein	
tyrosine	phospha-
tase,	cell	growth,	dif-
ferentiation,	mitosis
H. pylori target Tyrosine		
phosphorylation		
of	CagA	toxin
(yamazaKi et al., 
2003)
RB1 Cell	cycle,	tumor	
suppressor	gene,	
H. pylori target
Mutations,		
differential		
expression
(lan et al., 2003)
RUNX3 Transcription	factor Tumor	suppressor	
gene,	H. pylori 	
related,	apoptosis,	
potential		
prognostic	factor
Inactive	by		
down-regulation	or	
methylated
(homma et al., 2006; 
ito et al., 2005)
STK11 Protein	kinase Tumor	suppressor	
gene,	Peutz-Jeghers	
syndrome	associat-
ed	gastric	cancer
Mutations (shinmura et al., 
2005)
TP53 DNA	binding,	tran-
scriptional	activa-
tion,	DNA	repair,	cell	
cycle	arrest,	apopto-
sis,	senescence
Tumor	suppressor	
gene,	Li-Fraumeni	
syndrome
Mutations Numerous
ZFHX3 Transcription	factor Aggressive	form Genetic	alterations (Cho et al., 2007B)
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has been identified as the most significant 
single environmental factor associated with 
the increased risk for developing gastric ad-
enocarcinoma in many epidemiological, 
case and animal model studies (Forman et 
al., 1991; Parsonnet et al., 1991a; Parson-
net et al., 1991b; Recavarren-Arce et al., 
1991; Watanabe et al., 1998). H.pylori in-
fection has been shown to cause changes 
that lead to development of pre-cancerous 
conditions and lesions, i.e., chronic gastritis, 
gastric atrophy, intestinal metaplasia and 
dysplasia (Craanen et al., 1992; Rugge et 
al., 1996; Watanabe et al., 1998). H.pylo-
ri strains, which carry the virulence factor 
cagA and produce vacuolating cytotoxin A, 
are particularly associated with gastric can-
cer (Atherton, 1997). Although the associ-
ation of H.pylori infection with gastric can-
cer is undisputable, the molecular genet-
ic mechanisms of how H.pylori infection 
promotes the gastric carcinogenesis still re-
main unknown.
Prolonged H.pylori infection and sequen-
tial precancerous process precedes gastric 
cancer. A multistep progression of gastric 
cancer includes chronic gastritis, atrophic 
gastritis, intestinal metaplasia, dysplasia 
and adenocarcinoma (Correa, 1992) (Fig-
ure 6). Gastritis and gastric atrophy elim-
inate gastric mucosa, which reduces gas-
tric acid secretion and neutralizes gastric 
juice. Elevated gastric pH allows chang-
es in the gastric flora and it also allows 
anaerobic bacteria to colonize in the stom-
ach. Anaerobic bacteria produce reductase 
enzymes that catalyze the nitrite synthesis 
from food nitrate. Nitrite reacts with amines 
and urea to produce carcinogenic N-nitroso 
compounds, which are capable of interacting 
with DNA. Carcinogenic agents initiate the 
progression from metaplasia to adenocar-
cinoma as DNA damage accumulates in 
the cells. H.pylori infection is involved in 
gastric carcinogenesis as it is the most fre-
quent cause of chronic gastritis and it de-
creases acid-pepsin secretion and ascorbic 
acid (dietary antioxidant) concentration in 
the stomach along with progressing muco-
sal atrophy. Furthermore, H.pylori colonies 
are observed overlaying and preceding le-
sions of the intestinal metaplasia.
H.pylori can adapt to the acidic environ-
ment of the stomach by secreting urease 
enzyme that metabolizes urea into ammo-
nium, which neutralizes hydrochloric acid 
and produces a neutral microenvironment 
around the organism (Dunn et al., 1990). 
What is more, H.pylori bacteria secrete vir-
ulence factors, which damage gastric epithe-
lial cells. Urease not only is a survival fac-
tor, it also functions as a virulence factor by 
inducing an inflammatory reaction (Har-
ris et al., 1996) and toxic effect in gastric 
epithelial cells (Smoot et al., 1990). In ad-
dition to urease, H.pylori virulence factors 32
Figure 6 
Sequential	progression	of	gastric	cancer
Figure	after	(Correa, 1992; PeeK and Blaser, 2002).
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include vacuolating cytotoxin A (VacA) and 
genes in the cytotoxicity associated gene 
pathogenicity island (cagPAI). VacA induces 
mucosal damage and is associated with gas-
tric carcinogenesis (de Figueiredo Soares 
et al., 1998). CagPAI genes encode a se-
cretion system (Covacci et al., 1999) that 
transfers an effector protein, cagA, into a 
host cell (Odenbreit et al., 2000). The cel-
lular membrane tyrosine kinase phosphory-
lates cagA (Covacci and Rappuoli, 2000). 
Phosphorylated cagA interacts with host 
signaling molecules, including SHP-2 
(Higashi et al., 2002), and causes mor-
phological changes in the epithelial cells 
(Moese et al., 2004). Especially cagA-posi-
tive strains are associated with gastric ade-
nocarcinoma (Blaser et al., 1995). Never-
theless, bacterial strains carrying the Cag-
PAI genes induce more intense inflamma-
tion than strains that lack cag genes (Kolho 
et al., 1999; Yamaoka et al., 1997). The in-
teraction between cag secretory system and 
host cell induces the inflammatory reaction 
(gastritis). Notwithstanding, production of 
pro-inflammatory cytokines (interleukin-8) 
in epithelial cells (Odenbreit et al., 2000) 
also occur without cagA involvement (Fischer 
et al., 2001).
In addition to direct H.pylori assault, en-
dogenous host responses are crucial in de-
termining the progression of H.pylori in-
fection in to pre-neoplastic lesions and ul-
timately gastric adenocarcinoma (Correa 
and Houghton, 2007) (Figure 7). H.py-
lori infection induces activation of NF-κB 
(Maeda et al., 2000), which then activates 
growth factors (e.g., Cyclin D1 and Myc) 
and suppressors of apoptosis (e.g., BCL-
XL) (Karin et al., 2002). Although in-
crease in cell turn-over is not directly associ-
ated with malignancy, excess propagation of 
cells increases the probability of mutations 
by inducing DNA damage from shortened 33
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Figure 7  
A	model	of		H. pylori	infection	induced	inflammation	and	gastric	cancer	promotion
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telomeres. Furthermore, NF-κB activation 
initiates COX-2 and prostaglandin pathways 
(Williams et al., 1999) that introduce mor-
phological changes in the epithelium. COX-2 
expression induces production of prosta-
glandin E2, which is a strong inducer of vol-
atile and detached phenotype that is charac- 
34
teristic of cancer cells. PGE2 production 
leads to the suppression of E-cadherin func-
tion and induces anchorage independence 
and contact inhibition (Weinberg, 2007). 
Pathogenic insult usually leads to an 
acute inflammation response and to a com-
plete clearance of the microbe, but in H.py-
lori infection, inflammatory process fails to 
eradicate the microbe, infection sustains 
B)
A)
HSR Normal Ladder
B)
A)
HSR Normal Ladder
Figure 8 
Manifestations	of	DNA	copy	number	amplification
A)	Homogeneously	staining	region	and	B)	Double	minute	chromosomes.		
Images	from	(sChwaB, 1998)	and	www.wikipedia.org.
HSR
A)
Normal Ladder
B)
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and a state of chronic inflammation devel-
ops (Correa and Houghton, 2007). A pro-
longed inflammation (chronic gastritis) and 
the subsequent atrophic gastritis serve as 
a platform for carcinogenesis by providing 
a suitable microenvironment for inducing 
DNA damage. The inflammation induces 
mutagenic hits by causing excess cell pro-
liferation (De Luca et al., 2003; De Luca 
et al., 2004), changes in the epigenetic reg-
ulation of the host gene expression (Nar-
done et al., 2007) and oxidative/nitrosa-
tive stress by inducing the production of re-
active oxygen and nitrogen species (Ernst, 
1999). The inflammatory cells produce cy-
tokines and chemokines (e.g., TNF-α) that 
act via NF-κB pathway (Karin et al., 2002; 
Weinberg, 2007) and increase the prolifer-
ation of epithelial cells. In the chronic H.py-
lori induced gastritis, the CpG islands of the 
promoter regions of several tumor suppres-
sor genes have been found to be hypermeth-
ylated (Kang et al., 2003). The hypermeth-
ylation of a promoter region is an epigene-
tic change that inhibits transcription and in-
duces gene silencing by blocking the bind-
ing of a transcription factor to its target se-
quence in the promoter. Activated leukocytes 
produce reactive oxygen species, namely ox-
ygen ions, free radicals and peroxides, and 
reactive nitrogen species as a means to at-
tack colonizing pathogens (Ernst, 1999). 
Oxygen and nitrogen metabolites are highly 
reactive due to the presence of an unpaired 
electron and they cause damage by reacting 
randomly and extremely rapidly with vari-
ous biomolecules, such as DNA, proteins 
and lipids. H.pylori infection promoted in-
flammation is amplified by the expansion 
of the inflammatory cell pool via NF-κB – 
TNF-α – cytokine pathways and DNA dama-
ge induced feedback loops. 
DNA copy number  
amplifications in human cancers
Many human cancers of different anatomi-
cal locations are characterized by DNA copy 
number amplifications. Amplification is a 
chromosomal change that results in an in-
crease of the copy number of a specific DNA 
region (Albertson et al., 2003; Lengauer 
et al., 1998). Even hundred-fold elevation 
in the gene copy number may be present 
in some tumors. Such high-level amplifica-
tions of MYC and EGFR oncogenes occur 
in neuroblastoma (Schwab et al., 2003) and 
glioma (Vogt et al., 2004), respectively. 
DNA copy number amplification is a local, 
intra-chromosomal mutation that affects a 
DNA segment of less than 20 million bp in 
length. DNA copies generated in amplifica-
tion manifest as concatenate homogenous-
ly staining chromosomal regions (HSRs) 
and extra-chromosomal acentric DNA frag-
ments (double minutes and episomes) 
(Albertson et al., 2003; Schwab, 1998). 
HSRs form a ladder-like structure of invert-
ed repeats within chromosomes (Schwab, 
1998) (Figure 8A). Double minute chromo-
some bodies are extra-chromosomal, circu-
lar DNA segments (Hahn, 1993) (Figure 
8B). An excess chromosome or chromo-
some segments, HSRs and double minute 
chromosomes can be detected using stan-
dard microscopic techniques (Schwab et 
al., 2003; Vogt et al., 2004) and compara-
tive genomic hybridization (CGH) (Kallio- 
niemi et al., 1992). Episomes are sub- 
microscopic extra-chromosomal DNA seg-
ments of ~250 bp in length, which can be 
detected with molecular biology methods, 
such as fluorescent insitu hybridization and 
microarray CGH (Graux et al., 2004; Mau-
rer et al., 1987). The amplified region may 
contain gene fusions, i.e., DNA from dif-
ferent genomic sites (Graux et al., 2004; 
Guan et al., 1994).
DNA copy number amplification resulting in 
the formation of a homogeneously staining re-
gion has been proposed to have occurred accor- 
ding to the Breakage-Fusion-Bridge (BFB) 
model (Figure 9). The event initiating in BFB 
sequence is a DNA double-strand break. Before 
cell division the uncapped chromosome 
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replicates. BFB sequence progresses if fusion 
of the uncapped sister chromosomes occur 
before chromosome segregation. During mi-
tosis the two centromeres of the dicentric fu-
sion chromosome are drawn to the oppo-
site poles of the mitotic spindle forming an 
anaphase bridge. DNA double-strand break 
in the new site during mitosis inflicts in-
verted duplication and loss of the genomic 
region between the two breakpoints in the 
daughter cells. The BFB cycle proceeds with 
every cell division, and the duplicated DNA 
region proliferates until the open chromo-
some ends are sealed. The steps of the 
BFB sequence, DNA double-strands break 
due to telomere loss (Murnane and Saba-
tier, 2004) and chromosomal breakage 
(Coquelle et al., 1997), sister chromatin 
fusion and breaking of the anaphase bridge 
(Shimizu et al., 2005) as well as ladder-36
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Figure 9  
Breakage-Fusion-Bridge	model	of	DNA	amplification
Figure	produced	after	Schwab,	1998	(sChwaB, 1998)
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like structure of inverted repeats (Toledo 
et al., 1992), have been proven to exist in
vivo.
The disintegration of circular extra-chro-
mosomal chromatin bodies (double min-
utes and episomes) from chromosome, un-
equal segregation in cell division and selec-
tion in tumor tissue is another mechanism 
which results in DNA copy number ampli-
fication (Graux et al., 2004; Hahn, 1993). 
Extra-chomosomal amplification most like-
ly occurs by unequal segregation in cell di-
vision and selection in tumor tissue, since 
double minutes and episomes rarely con-
tain replication origins or centrosome that 
would enable propagation by replication 
and mitotic segregation. Extra-chromosom-
al DNA elements are thought to rise either 
before or after replication. Chromosomal 
deletion occurs if a DNA segment loops out 
from the chromosome before replication 
and chromosome ends are joined. There is 
evidence that supports the model that ex-
tra-chromosomal DNA is looped out from 
the genome, since original genomic archi-
tecture has been shown to remain together 
in the MYCN amplification (Schneider et 
al., 1992) and excised double minute (Tole-
do et al., 1993). It has also been shown that 
episomes (Graux et al., 2004) may carry 
DNA that is deleted in the original genomic 
region. If double minute excision happens 
after replication, the excised DNA segment 
stays also in the chromosome. There are two 
models for postreplicative multiplication of 
double minutes (Vogt et al., 2004) (Figure 
10A and B). Double minutes may unfold 
via breakage of the replication bubbles and 
multiply due to unequal segregation during 
mitosis. Furthermore, double minutes may 
contain inverted, repeated sequences sug-
gesting that double minute formation may 
happen by HSR breakdown and the circu-
larization of the derivative DNA fragments 
(Fakharzadeh et al., 1993; Singer et al., 
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Figure 10 
Models	of	double	minute	formation
A)	Segregation	after	replication,	B)	Breakage	of	the	
replication	bubles	and	C)	HSR	breakdown.	Figure	
produced	after	Vogt	et	al.,	2004	(Vogt et al., 2004).
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2000) (Figure 10C). In proportion, DNA 
double-strand breaks may induce genomic 
relocation of double minutes and episomes 
resulting in formation of HSRs or distribut-
ed insertions (Coquelle et al., 1998). Even 
though current data supports the excision-
segregation-selection models of extrachro-
mosomal amplification, also episomal pro-
liferation (autonomous plasmid-like replica-
tion of sub-microscopic circular molecules) 
(Von Hoff et al., 1988) and recombination 
to form double minutes that reinsert into 
the chromosomes (Von Hoff et al., 1990) 
have been proposed to result in DNA am-
plification.
Models of DNA amplification mecha-
nisms, BFB sequence and excision of extra-
chromosomal DNA segments, stipulate that 
two independent DNA double-strand breaks 
that flank the amplified region are required 
to occur in order to make DNA amplification 
possible. There are numerous agents and 
processes that have been shown to induce 
DNA double-strand breaks. Tobacco, etha-
nol and caffeine contain clastogenic chem-
icals that cause chromosomal breaks (Ban 
et al., 1995; Kuwano and Kajii, 1987; Rao 
et al., 1988). Asbestos is a group of silicate 
fiber, which is associated with the risk of de-
veloping lung cancer. Asbestos fibers block 
cell division, puncture into the nucleus and 
physically irritate the chromatin, suggest-
ing a mechanism for inducing chromosome 
breaks (Jensen et al., 1996). Exposure to 
radiation is an established extrinsic cause 
of chromosomal breaks (Ban et al., 1995). 
The Vprgene encoded protein induces chro-
mosomal breaks leading to amplifications 
in patients infected with human immuno-
deficiency virus (Shimura et al., 1999). Fo-
late and oxygen deficiencies (Blount et al., 
1997; Coquelle et al., 1998) and release of 
oxygen-free radicals (Marnett, 2000) are 
intrinsic cellular processes that have been 
associated with the DNA damage.
Human genome is not consistently dura-
ble and resistance to DNA breaks varies be-
tween different regions. Specific DNA se-
quence features have been proposed to in-
crease damage susceptibility. Fragile sites 
are genomic regions, which are damage-
prone when cells are treated with chemicals 
that interfere with replication (Schwartz et 
al., 2006). There are 120 fragile sites in the 
human genome according to the Nation-
al Center for Biotechnology Information 
database (http://www.ncbi.nlm.nih.gov/). 
Eighty-eight fragile sites are classified as 
common, since they are found in all indi-
viduals, and 31 fragile sites, which are found 
in less than 5 % of the population, as rare. 
Damage susceptibility of the fragile sites 
varies and it has been shown that 15 % of 
all the common fragile sites contained 75 
% of the DNA breaks (Glover et al., 1984). 
Fragile sites harbor large genes. WWOX and 
FHIT genes are 1.1 Mb and 0.8 Mb in length 
and located in two most damage-prone com-
mon fragile sites (FRA16D in 16q23.1 and 
FRA3B in 3p14.2) (Iliopoulos et al., 2006). 
In addition, fragile sites in general are en-
riched with extremely large genes (Smith et 
al., 2006). Chromosomal fragility induced 
breaks have been proposed to initiate the 
amplification pathway (Coquelle et al., 
1997). Specifically, the common fragile sites 
were shown to coincide with amplification 
boundaries in a cell line experiment (Hell-
man et al., 2002). Furthermore, MET onco-
gene amplifications in six primary esopha-
geal adenocarcinomas contained at least 
one break point that was located within a 
fragile site (Miller et al., 2006). 
According to the central dogma, DNA in-
formation, including copy number, is trans-
ferred to RNA. The information encoded in 
the DNA copy number does not transfer in-
to RNA quantity in a strict proportion be-
cause transcription is in many ways regu-
lated. However, increased gene copy num-
ber generally induces elevated gene expres-
sion but the impact of gene amplification 38
on gene expression differs between cancer 
types, and it also depends on the structure 
of the amplicon. It has been estimated that a 
2-fold change in DNA copy number causes 
a 1.5-fold difference in the mRNA level (Pol-
lack et al., 2002). In studies of primary 
breast tumors (Hyman et al., 2002; Pol-
lack et al., 2002) 44% to 62% of highly 
amplified genes were found to be overex-
pressed. In contrast, only 19.3% of the am-
plified genes in prostate cancer cell lines 
were shown to be overexpressed (Wolf et 
al., 2004). 
Oncogene amplification promotes carci-
nogenesis as an amplified ERBB2 gene was 
found to induce abnormal development of 
mammary glands and eventually initiate the 
tumorigenesis of the breast in a mouse mod-
el (Andrechek et al., 2000). According to 
a very  conservative estimate, there are over 
40 oncogenes that have been identified to be 
activated  by copy number amplification in 
human cancers (causes increased gene ex-
pression or specifically associates with clin-
ical outcome or tumor biology) (Myllykan-
gas et al., 2007). Most studied amplified 
genes in human cancers include AKT2 in 
ovarian cancer, ERBB2 in breast and ovari-
an tumors, MYCL1in small cell lung cancer, 
MYCN in neuroblastoma, REL in Hodgkin 
Lymphoma, EGFR in glioma and non-small 
cell lung cancer and MYC in various cancers 
(Futreal et al., 2004).
Drug target gene amplifications fre-
quently induce resistance to drug thera-
py as asserted in laboratory experiments 
using cell lines as well as in clinical stud-
ies (Goker et al., 1995; Johnston et al., 
1983; Shannon, 2002; Wahl et al., 1979). 
The CAD gene amplification is a common 
mechanism in conducting resistance to 
N-(phosphonacetyl)-L-aspartate mediated 
genotoxicity (Wahl et al., 1979). Methotrexate 
is an inhibitor of the DHFR enzyme that 
is used in treatment of various cancers. 
Methotrexate resistance has been shown to 
result from the DHFR gene amplification 
in hamster cell lines (Johnston et al., 1983) 
as well as in patients with acute lymphoplas-
tic leukemia (Goker et al., 1995). Imatinib 
mesylate is a BCR-ABL fusion protein in-
hibitor, which has been successfully applied 
in the treatment of CML patients. Imatinib 
mesylate treatment resistance occurs in 
some of the patients due toBCR-ABL fu-
sion gene amplification or mutations in the 
ABLgene (Shannon, 2002). Additionally, 
changes in metabolite, substrate and com-
petitive enzyme fluxes may underlie some 
cases of Imatinib mesylate resistance (Bo-
ren et al., 2001; Boros et al., 2002).
Oncogene amplifications occur frequent-
ly in advanced cancers and in the majori-
ty of organs and they usually are associated 
with poor prognosis (Myllykangas et al., 
2007). Amplifications are more common in 
solid tumors than hematologic malignan-
cies (Myllykangas et al., 2007). Although 
the gain-of-function effect of gene amplifi-
cations is very a appealing target for modern 
small molecule inhibitors, only therapeutic 
agents targeted at ERBB2 and EGFR ampli-
fications are currently available (Myllykan-
gas et al., 2007). The EGFR gene is fre-
quently amplified in colorectal cancers and 
there is a monoclonal antibody (panitumab) 
that binds to EGFR and inhibits its function. 
The RAS oncogene encodes a signal trans-
duction protein that is downstream of EGFR. 
Nevertheless, patients with mutations in 
the RAS gene do not respond to EGFR 
antibody treatment and, in fact, the latest re-
ports indicate that patients with RAS muta-
tions have worse prognosis using EGFR an-
tibodies than with traditional therapies. ❦
39
Genomic and functional 
profiling of gastric cancer
Review
 of the literature

The treatment of cancer ultimately requires a detailed knowl-
edge about the molecular properties of tumors. The complexity and 
heterogeneity of gastric cancer suggests that the genome-wide ap-
proach is well justified to study its molecular properties. The ge-
nome-wide methods can be used to detect genomic changes in can-
cer and to link them with cellular functionality and cancer pheno-
type. Novel microarray technologies for measuring gene expression 
and copy number allow molecular-level dissection of the function-
al and structural genomic changes in cancer. It is possible to define 
the cancer biomarkers and genes associated with the cancer pheno-
type using a multi-level, high-throughput genomic profiling, clini-
cally and biologically relevant background data and computational 
data mining. Gastric cancer is a well-suited model for studying can-
cer since it is fairly common, it has well-documented epidemiolog-
ical and biological background and it mani-
fests many characteristics that are common 
to human cancer. More explicitly, the asso-
ciation of gastric cancer with H.pylori infec-
tion allows the research of carcinogenesis 
and cancer initiation. The biological back-
ground of cancer can only be understood 
if different cancer types can simultaneous-
ly be studied. Exploring DNA copy number 
amplifications in a landscape of cancers al-
lows the uncovering of biomolecular funda-
mentals behind cancer and the confluences 
between different cancer types. ❦
Hypotheses  
and objectives  
of the research
The scientific objectives  
of the thesis were to:
•		Identify	gene	expression	changes	and	gene	regulatory	
networks	in	H. pylori infected	cells	(I	and	II)
•		Identify	putative	target	genes	in	gastric	cancer	(III)
•		Discover	biological	fundamentals	behind	DNA	copy	
number	amplifications	in	cancer	(IV	and	V)
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A brief overview of the materials and methods is presented in 
the following sub-sections. More detailed technical descriptions can 
be found in the corresponding publications.
In vitro model of H. pylori infection (I and II)
Laboratory experiments (invitro) are needed in order to study the 
specific properties in biological systems. Laboratory experiments al-
low the researchers to have control over different biological, phys-
ical, and chemical properties, and focus the measurements on the 
specific biological properties. H.pylori infection induced gene ex-
pression changes in human epithelial cells and they were studied 
invitro using H.pylori strain NCTC 11637 and AGS cell line (I). H.
pylori strain NCTC 11637 met the requirements of a pathogen in the 
experiment, since the virulence factors cagA and vacA were present 
(Jiang et al., 1996). AGS cell line (the American Type Culture Col-
lection, Manassas, MA) was chosen to be the host in the invitro ex-
periments as its growth characteristics, monolayer, resembled the 
gastric epithelium. Moreover, AGS cell line contains less genomic 
changes compared to other stomach cancer cell lines. AGS cell line 
has previously been used as a model host in H.pylori studies. There-
fore, it is possible to compare results with the previous data.
Clinical gastric cancer samples (III)
Experiments carried out in the laboratory are not equivalent to the 
natural phenomenon. That is why it is also important to study the 
original samples. Clinical gastric cancer samples were collected pro-
spectively in the Department of Surgery (Helsinki University Cen-
tral Hospital, Helsinki, Finland) (III). Ethical issues had to be met 
so that the privacy of the patients who participated in the study was 
Materials  
and Methods
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protected. The study was authorized by the 
Clinical Review Board of Helsinki Univer-
sity Central Hospital and the research proj-
ect was reviewed and approved by the Ethi-
cal Committee of the Department of Medi-
cal Genetics. Each participant signed a letter 
of consent prior to entering the study. Gas-
tric cancer samples were collected between 
1999 and 2005 during surgical removal of 
the stomach (gastrectomy). Extra precau-
tions were taken in the sample preparation, 
since downstream analysis using microar-
rays is very sensitive. Sample quality deter-
mines the quality of the measurement data. 
In order to preserve the integrity of the nu-
cleic acids, samples were taken immediately 
after the gastrectomy. Cancer samples were 
taken from the tumor site and normal tissue 
was obtained as far away from the tumor 
site as possible. Subsequently, samples were 
fresh frozen in liquid nitrogen and stored in 
-80 °C in as to preserve DNA and RNA from 
degradation. The collection of stomach spec-
imens included a total of 375 samples. In or-
der to ensure the anonymity of the partici-
pating patients, generic sample codes were 
given to each collected tissue sample by the 
attending clinician and all personal data was 
eliminated when tissue samples were sub-
jected to research. 
Classification of gastric cancer  
histology (III)
The classification of gastric cancer was de-
fined according to Laurén (LaurÉn, 1965). 
The tissue samples used in the histopa-
thology were surgical specimens from gas-
tric cancer patients (see previous section). 
The classification was performed by a pro-
fessional pathologist in Helsinki Universi-
ty Central Hospital (HUSLAB). The histo-
pathological classification was performed 
using the frozen section preparations from 
the samples. The main stains used in the 
classification experiments were HE and 
Alcian blue-PAS. The patient records at the 
department of pathology were used to col-
lect the clinical data. 
Microarray experiments (I, III)
Nucleic acid extraction (I, III)
Total RNA was extracted from infected and 
non-infected cell lines using the Qiagen 
RNeasy method (I). DNA was extracted from 
the homogenized clinical gastric samples us-
ing the DNeasy tissue extraction kit (Qiagen) 
and total RNA was extracted using the RNeasy 
midi kit (III). The same homogenates were 
used in RNA and DNA extraction. The con-
centrations of DNA and RNA samples were 
measured using Eppendorf Biophotometer 
(Eppendorf AG, Hamburg, Germany) and 
the nucleic acid quality was measured using 
gel electrophoresis and Agilent’s 2100 Bioan-
alyzer (Agilent Technologies) (I and III).
Hybridization (I, III)
The gene expression profile of H. pylori 
NCTC 11637 infected AGS cell line was mea-
sured using custom-printed microarray con-
taining 12,000 cDNA probes (I). For each 
hybridization, 50 µg of the total RNA was 
extracted from H.pylori infected cell lines, 
and non-infected cell lines were labeled with 
fluorescent dyes using reverse transcription 
enzyme. The labeled cDNAs were hybrid-
ized on a cDNA microarray as previously de-
scribed (Mousses et al., 2000).
The integration of gene copy number and 
the expression of microarray data is also re-
quired to understand the effects of gene reg-
ulation and transcription in the manifesta-
tion of genomic copy number changes. For-
ty-six gastric tissue samples were selected 
based on the sample quality and were ana-
lyzed using array comparative genomic hy-
bridization (aCGH) and gene expression 
microarrays (III). The gene expression in 
46 gastric tissues (8 normal and 38 cancer 
samples) was studied using a commercial 
microarray kit with 44,000 oligonucleotide 
probes. Twenty μg of total RNA was used in 44
hybridization. An RNA pool of 10 non-gas-
tric cancer cell lines was used as a reference. 
Using a universal reference that contains a 
genome-wide coverage of transcribed genes 
allows the measuring of more genes. If the 
gene that is expressed in the test sample 
is not expressed in the reference sample, 
it is not possible to get a result, since ra-
tio cannot be calculated if the reference is 
zero. The labeling of the test and reference 
RNAs, hybridizations and wa shings were 
carried out according to the manufacturer’s 
instructions. 
For performing aCGH, DNA samples were 
labeled as previously described (Hyman et 
al., 2002; Wolf et al., 2004). Pooled DNA 
extracted from the gender-matched healthy 
individuals’ blood’s buffy coat fraction ob-
tained from the Finnish Red Cross was used 
as a reference. Twenty μg of genomic DNA 
from test sample and reference sample were 
used in the hybridization experiment. DNAs 
were labeled using fluorescent dyes and re-
verse transcription enzyme. The manufac-
turer’s instructions were followed in the hy-
bridization and washing of the slides.
Microarray data analysis (I, III)
Microarray data preprocessing (I, III)
After the hybridization experiments, micro-
array slides were scanned using a confocal 
laser scanner and the fluorescence intensi-
ties of the DNA spots were measured. Two 
scans were performed for each microarray 
slide to produce fluorescence intensity im-
ages for both, test and reference channels. 
Image analysis software is required in or-
der to interpret scanned images from TIFF-
format into numeric values as well as to ob-
tain a text file of raw intensity values for test 
(Cy5) and reference (Cy3) channels. The im-
age analysis was performed using DEARRAY 
software (Chen et al., 1997) (I) or Feature 
Extraction software 8.1 (Agilent Techno- 
logies) (III). 
Data from different measurements and 
arrays had to be normalized to be able to 
compare the different data from the differ-
ent samples. All normalizations were done 
using GeneSpring software. Lowess nor-
malization was applied on the data set using 
GeneSpring 5.0 data analysis software (Sili-
con Genetics, Redwood City, CA) (I). aCGH 
and gene expression microarray normal-
izations were carried out using the Feature 
Extraction data import plug-in with default 
parameters for 2-color microarrays (Agilent 
Technologies) (III). Outlier features were 
disregarded in the normalization.
Filtering the results by quality parameters 
is required to make certain that all the da-
ta that enters the downstream analysis is of 
good quality. Intensity data were imported 
into the GeneSpring data analysis software 
(Agilent Technologies). Data were filtered 
by requiring the measurement quality score 
of the DEARRAY software to be more than 
0.5 (Chen et al., 2002) (I). The genes that 
passed the quality control had spot fluores-
cence intensity over two times higher than 
the variance of the background, the intensi-
ty of the test sample was over 200, and the 
area of the spot was over 25. Microarray re-
sults in publication III were quality filtered 
using outlier and control flags determined 
by the Feature Extraction Software.
In order to be able to interpret the results 
from the microarray experiments it is im-
portant to know exactly what the arrayed 
probes are measuring. One efficient and 
stable technique is to match the probe se-
quences in the human genome sequence 
and extract gene annotations through the 
genomic databases. In publication III, the 
DNA sequence information of the probes 
was provided by the manufacturers of the 
microarrays that were used in the study. 
The corresponding genomic map positions 
of the microarray probes were retrieved us-
ing MegaBlast analysis against the human 
genome sequence.  Each microarray probe 
was assigned with an Ensembl gene identi-
M
aterials and M
ethods
45
Genomic and functional 
profiling of gastric cancer
fier according to the map positions of the 
probe sequences. The gene identifications 
of Ensembl were applied to collect gene an-
notation data.
Identifying H. pylori  
infection regulated genes (I)
The genes that were regulated in AGS cells 
by co-culture experiments of H.pylori stim-
ulation were identified by filtering data in 
different time points (I). A cut-off of two-
fold change in gene expression ratios was 
used to select genes regulated during the H.
pylori stimulation time series. In addition to 
this, t-test (p<0.05) was used to select differ-
entially expressed genes in individual time 
points. The accumulation of H.pylori reg-
ulated genes in chromosomal regions that 
contain frequent changes in gastric cancer 
was assessed using a statistical hypothesis 
testing. P-value correction (e.g., False Discov-
ery Rate) was not used when determining 
statistical significance in the analysis of the 
result genes since the identified genes were 
used for hypothesis generation and the in-
dividual findings were further validated us-
ing alternative methods. On the other hand, 
downstream-analysis was carried out using 
the whole set of genes.
Identifying gene copy number  
alterations in gastric cancer samples (III)
In microarray-based comparative genomic 
hybridization, the copy number of the gene 
is quantified and reported by a relative and 
continuous scale. Microarray data is noisy 
and when thousands of genes are measured 
simultaneously, individual measurements 
can vary unintentionally. Consequently, it 
is difficult to determine gene copy number 
changes based on a single measurement. In 
aCGH, measurements are not independent 
but interconnected by genomic location. As 
a result the measurements of the neighbor-
ing genomic positions have a higher prob-
ability of representing the same amount of 
genomic DNA. The dependency between 
probes representing close-by genomic ele-
ments can be taken into account when the 
genomic regions of copy number changes 
are determined. The CGH Explorer soft-
ware (Lingjaerde et al., 2005) was applied 
to identify DNA copy number changes in 
38 gastric tumors (III). Analysis of copy er-
rors algorithm and false discovery rate of 
0.002 were used in the analysis. Copy num-
ber gains and losses were determined for 
each tumor sample and the frequency pro-
file across the genome was reported.
Classifying gastric cancer samples  
based on gene copy number aberrations (III)
The classification of samples is an elemen-
tal problem in clinical practice. Proper clas-
sification and diagnosis are the foundation 
of any effective treatment, as it is the in-
formative follow-up of the disease. Gener-
al concept in diagnostics is to determine, 
based on some continuous measurement 
value, whether a patient has a given condi-
tion or not. For example, what bodily tem-
perature is considered as fever or does a pa-
tient have a specific gastric cancer sub-type 
based on the genomic properties of the tu-
mor. There are four different outcomes of a 
two-class classification problem, such as in-
testinal or diffuse gastric cancer sub-type. 
True outcomes are achieved, when predic-
tion and actual value are the same. This can 
be the case when an actual intestinal type 
sample is predicted to be intestinal or if a 
diffuse type is predicted to be diffuse. Con-
versely, false outcomes ensue, if an actual 
value is different from the predicted value, 
when intestinal type is predicted to be dif-
fuse type and vice versa.
Receiver operating characteristics (ROC) 
analysis (Swets, 1998) was used to assess 
the values of gene copy number changes 
as classifiers of intestinal (n=25) or diffuse 
(n=13) type gastric tumors and cancers locat-
ed in corpus (n=19) or antrum (n=19) (III). 46
The gains and losses were treated separately 
in the analysis. ROC curve can be drawn by 
calculating the true and false positive rates. 
The area under the ROC curve was calcu- 
lated and these values were used to estimate 
the diagnostic value of a given gene.
ROC analysis identified gene groups that 
were too large for diagnostics use, since in 
clinical applications, patterns of no more 
than a few genes are sought after. More-
over, identifying a small subset of classi-
fier genes would be more informative in 
determining the biological significance of 
the genomic changes that determine the 
phenotypes of different subtypes. Forward 
selection algorithm and a Naïve Bayes classifier 
(Duda et al., 2001) were applied to identi-
fy the patterns of genes that would be ideal 
when classifying gastric cancer patients 
based on the tumor location or subtype. 
Ten-fold cross-validation procedure was per-
formed and repeated 50 times to ensure the 
stability of the identified patterns. Ten-fold 
cross-validation was chosen as it is optimal 
for such a small sample size. The number 
of genes in each pattern was determined by 
minimizing the validation error of 500 rep-
etitions with different subsets of data in the 
framework of maximum likelihood. The sig-
nificance of the identified patterns was as-
sessed by comparing them to randomly se-
lected variables. Ten thousand Naïve Bayes 
classifers were trained with randomly se-
lected variables and the performance of the 
true classifier was evaluated using a statis-
tical hypothesis test.
Integration of gene expression  
and copy number data from paired  
gastric cancer samples (III)
DNA copy number change does not nec-
essarily mean that all the genes inside the 
changed region would be implicated in can-
cer. It is more likely that there is a subset of 
genes within the changed region that con-
tributes to the manifestation of the cancer-
ous phenotype. Integrating the knowledge 
of gene expression intensity with the copy 
number is a powerful tool for separating 
the biologically relevant driving genes from 
the by-standers. Paired gene expression and 
copy number data from 38 gastric cancer 
tissues were integrated in order to identify 
genes that were differentially expressed due 
to copy number aberration according to the 
method reported by Hautaniemi et al. (Hau-
taniemi et al., 2004) (III). Array CGH and 
gene expression microarray probes were 
combined using the genomic map positions 
of the arrayed probes. Gains and losses were 
treated separately in the analysis. The copy 
number aberration labels were used to clas-
sify samples into two groups. Subsequently 
the mean gene expression levels were calcu-
lated for each group. Signal-to-noise statis-
tics and 10,000 random permutations of the 
label vectors were used to assess the signifi-
cance of the difference in the mean gene ex-
pression intensities between the compared 
groups.
Validation of  
the microarray results (I, III)
Gene discovery approach using microarrays 
is often disturbed by noise in the data and 
the candidate genes need to be further ex-
amined in order to validate the results and 
estimate the relevance of the findings. Gene 
expression changes in AGS cells caused by 
H.pylori stimulation were verified using real-
time PCR and target genes in gastric cancer 
were validated in protein level by immuno- 
histochemistry and tissue microarray. 
Quantitative real-time  
polymerase chain reaction analysis (I)
Quantitative real-time polymerase chain reaction 
(PCR) is a technique that can be used to de-
tect and quantify the amount of a specific 
DNA sequence in a sample. The procedure 
follows basic PCR but the accumulation of a 
PCR product is measured after each amplifi- 47
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cation cycle. When RNA is used as a tem-
plate it has to be reversely transcribed in-
to cDNA before quantitative PCR reaction. 
Quantitative real-time PCR was applied to 
validate the expression of ten genes reg-
ulated by H.pylori infection (I). Gene ex-
pression was measured in two time points 
and the untreated cell line was used as a 
control. For each analyzed gene a specific 
pair of primers were designed and synthe-
sized. Quantitative real-time PCR was run 
using Light Cycler thermal cycler and SYBR 
green detection system. Duplicate PCR re-
actions were executed for each gene. A neg-
ative control accompanied each run. Stan-
dard curves were obtained by performing 
serial dilutions of beta-globulin gene. The 
ACTB gene (beta actin) was used as an in-
ternal control and for the normalization of 
RNA quantity and quality differences in all 
samples.
Immunohistochemistry  
using tissue microarray (III)
Immunohistochemistry is a laboratory 
technique, which utilizes antibodies to de-
tect specific antigens in tissues. Antibodies 
(immunoglobulins) are proteins that are 
produced by cells of the immune system to 
identify and neutralize foreign agents. Each 
immunoglobulin binds to a specific anti-
gen. Physiological antigens are often biolog-
ical components that are specific to the inva-
sion of bacteria and viruses, but specific an-
tibodies against various antigens can be pro-
duced. Tissue microarrays consist of hun-
dreds of separate tissue specimens punc-
tured into a paraffin block. Using immuno-
histochemistry on tissue microarray enables 
simultaneous analysis of specific antigens 
in multiple samples. The specific antibodies 
that attach to ERBB2 and MUC-1 proteins 
were used on gastric cancer tissue microar-
ray of 78 specimens to validate cancer bio-
marker discoveries made using integrated 
gene copy number and expression analysis 
of the clinical gastric cancer samples (III). 
The tissue microarray used in the study was 
independent of the samples that were used 
in the microarray profiling.
Analysis of H. pylori infection  
regulated transcription factors and  
signaling pathways in AGS cells (II)
Rapid changes in the gene expression of 
AGS cells after H.pylori infection suggest-
ed that the host responses are controlled by 
signal transduction pathways that regulate 
the activity of specific transcription factors. 
Transcription factors are proteins that bind 
to specific DNA sequence after being acti-
vated by specific signals and regulate, either 
by increasing or decreasing, the expression 
of specific target genes. Transcription fac-
tor activation is a rapid mechanism for cells 
to respond to environmental stimuli by ac-
cordingly changing their gene expression. 
Consequently, the hypothesis was that us-
ing the gene expression data from H.py-
lori experiments and a bioinformatics ap-
proach, it would be possible to reverse engi-
neer the gene regulatory networks activated 
after H.pylori infection. The transcription 
factors and signal transduction pathways 
that were associated with H.pylori infection 
were charted by making use of phylogenetic 
footprinting and transcription factor bind-
ing site mapping on the regulated genes´ 
promoter regions (II). More reliable conclu-
sions about the regulatory backgrounds of 
the gene expression changes were allowed 
to be made by studying the entire H.pylori 
transcriptome. 
Computational analysis of  
H. pylori infection regulated signal  
transduction pathways in AGS cells (II)
H.pylori target genes (n=200) in AGS cells 
were previously identified using an invitro 
model and gene expression microarrays 
(I). Two kilobases of DNA upstream from 
the predicted transcription start site were 48
extracted in order to collect the regulatory 
DNA elements, promoters, of the H.pylori 
infection target genes. Similarly, the puta-
tive promoter regions were collected from 
400 randomly picked reference genes. 
Orthologous mouse genes were selected 
for H.pylori target and reference genes and 
their promoter regions were extracted using 
Ensembl database (Birney et al., 2004). 
Phylogenetic footprinting was applied 
to identify the conserved regions in the 
paired human-mouse promoter sequences 
(Lenhard et al., 2003). The DNA sequences 
that are evolutionary conserved are likely to 
have function and, thus, contain regulatory 
DNA elements (Lenhard et al., 2003). 
Transcription factor binding sites were 
mapped to the promoter sites that were evo-
lutionary conserved using the application 
on Consite website (Lenhard et al., 2003). 
The transcription factor binding sites were 
collected from the JASPAR database (Sand-
elin et al., 2004). The frequencies of tran-
scription factor binding sites in H.pylori in-
fection regulated transcriptome and refer-
ence gene set were counted and the statisti-
cal hypothesis testing was applied in order 
to test the enrichment of the binding sites 
of specific transcription factors. BioCarta 
pathway database (http://www.biocarta.
com/genes/index.asp) and database of Santa 
Cruz Biotechnology, Inc. (Santa Cruz, Ca) 
were used to collect annotation data for tran-
scription factors.
Validation of NF-κB transcription  
factor activation after H. pylori stimulation  
of AGS cells using electrophoretic mobility 
shift assay (II)
An electrophoretic mobility shift assay (EMSA) 
is a laboratory technique that is employed 
when studying protein-DNA interactions. 
Proteins and radio-labeled DNA are mixed, 
and radioactivity is detected using gel elec-
trophoresis separation. Specific antibodies 
are used to identify proteins that bind to 
radio-labeled DNA. EMSA technique was 
used to identify binding of NF-κB transcrip-
tion factor to its target DNA sequence after 
H.pylori stimulation of AGS cells. A simi-
lar invitro model was utilized as previous-
ly described (I). Upon activation, transcrip-
tion factors translocate from cytosol to the 
nucleus, where they bind to a specific DNA 
sequence. The nuclear proteins of H.pylo-
ri infected cells were extracted in order to 
study the transcription factor activation of 
NF-κB. Nuclear protein extracts were mixed 
with radio-labeled target DNA sequence of 
NF-κB. Shift assays and specific antibodies 
against p50 and p65 subu nits were used to 
determine NF-κB transcription factor com-
plex activation.
In silico analysis of DNA copy  
number amplifications in human  
cancers (IV, V)
The insilico analysis of DNA copy number 
amplifications in human cancer present-
ed in this thesis can be classified as applied 
computational biology. Various computa-
tional tasks were executed in order to dis-
cover novel information from a data collec-
tion of DNA copy number amplifications in 
a cross-section of human cancers.
Collection of DNA copy number  
amplifications in human cancer (IV, V)
DNA copy number amplifications were ob-
tained from a publicly available data collec-
tion (Knuutila et al., 2000) (IV and V). 
The data was curated from 838 original 
peer-reviewed research articles of chromo-
somal comparative genomic hybridization 
studies in cancer that were published be-
tween 1992 and 2002. The data collection 
contained 23 284 cases of which 4 590 cas-
es had amplifications. The amplifications 
were mapped to chromosome sub-band res-
olution (n=393) (Shaffer and Tommerup, 
2005). The amplifications were presented 
for each case by binary vectors of amplifi-49
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cation observations, where zero denoted a 
non-amplified chromosome band and one 
amplified chromosome band. Data matrix 
was assembled by piling data vectors.
DNA copy number amplification profiling (IV)
The cancer cases were classified according 
to the World Health Organization guide-
lines (Kleihues and Sobin, 2000 – 2006) 
and neoplasm groups (n=73) were formed 
in relation to the collected classification da-
ta (IV). The genome-wide amplification fre-
quency profiles were defined for each neo-
plasm type. A hierarchical clustering was 
applied to evaluate the similarities of am-
plification frequency profiles between the 
different neoplasms. Average amplification 
frequencies for each neoplasm group were 
used in the clustering.
Identification of amplification  
hot spots in the human genome (IV)
Computational methods can be very use-
ful when extracting meaningful data from 
large data sources that are often affected by 
noise. The database of DNA copy number 
amplification is somewhat affected by noise 
due to inconsistencies in the literature and 
limitations in the traditional CGH meth-
od. The independent component analysis 
(ICA) (Hyvärinen et al., 2001) is a compu-
tational method that aims at finding statis-
tically independent components in the data. 
The independent components are the mul-
tivariate factors that are composed of mul-
tiple signal sources. The components are 50
Figure 11 
DNA	copy	number	amplifications	in	chromosome	1
Original	data	from	over	400	cases	with	amplifications	that	were	collected	
from	the	literature	(IV).	Cancer	cases	are	in	random	order.
formed by maximizing their statistical in-
dependence. The ICA method was applied 
in order to identify preferential amplifica-
tion sites in the human genome as it was 
presented earlier by Himberg et al. (Him-
berg et al., 2004) (IV). For an optimal per-
formance, it is important to reduce noise by 
lowering the dimensionality in the data. The 
principal component analysis (PCA) (Duda 
et al., 2001) was used to reduce noise and 
to select the 60 components with the largest 
eigenvalues. After PCA whitening, the ICA 
analysis was performed and, the 30 most 
stable components in the data were selected 
and sorted using the stability indexes. The 
identified ICA components represented the 
regions in the human genome that are pref-
erentially amplified.
Modeling and clustering  
DNA copy number amplifications (V)
In science, models are often used to explore 
new ideas and concepts and to disseminate 
information. The models are often helpful 
when it is difficult to comprehend the prop-
erties of the studied phenomenon, or if it 
is difficult to circulate the findings among 
peers. In traditional molecular biology, 
where single isolated events were studied, 
it was possible to present the measurement 
data or experiment outcomes in raw format, 
as simple tables or images, which were com-
prehensible and informative as a basis of in-
terpretation. Modern genomics applications 
measure tens of thousands of data points si-
multaneously, and raw measurement data is 
presented in high-resolution images of ar-
rayed hybridization signals and data files of 
tens of megabytes in size. It is evident that 
these array images and result tables no lon-
ger are comprehensible and useful for hu-
mans when interpreting the results. As a re-
sult, by definition, genome-wide microarray 
data are incomprehensible and impossible 
to distribute in its original format and data 
needs to be described with the appropriate 
visual or exploratory models. Fortunately, 
computers are fast and precise in handling 
large images and data files. It is therefore 
natural that computational methods have 
become instrumental in modeling genomic 
-scale data.
DNA copy number amplifications (Figure 
11) were modeled in order to explore the bi-
ological fundamentals in the amplifications 
and form a classification based on amplifica-
tions (V). Machine learning techniques were 
applied to model inherent structures of the 
DNA copy number amplifications. DNA copy 
number amplifications were modeled for 
each chromosome separately. Finite mixture 
models of Bernoulli distributions were used 
in the modeling experiment. Expection- 
Maximization algorithm (Everitt and Hand, 
1981) was applied in estimating the models 
and in selecting the complexity of the mod-
els in a chromosome (Tikka et al., 2007). 
DNA copy number amplification models 
can be used to determine sample groups 
with a similar amplification pattern. The 
clustering of the cancer cases based on the 
amplification models was executed as pre-
sented earlier.
Finite descriptions of the DNA  
copy number amplification models (V)
Even when probabilistic models are effec-
tive in describing the data, they may not 
be optimal when interpreting or distribut-
ing the findings. The models are represent-
ed as arrays of probability values that may 
be readily visualized. In order to fully inter-
pret them, it is required for the models to 
be described in the original language of the 
chromosome bands. This ensures that fur-
ther exploration becomes possible and rele-
vant background data can be integrated in 
the models. Moreover, after translating the 
models into finite and comprehensible de-
scriptions, the cancer specialists are able to 
relate to them. Maximal frequent itemset 
mining (HollmÉn and Tikka, 2007) was 51
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used in the identification of the finite and 
comprehensible descriptions of the identi-
fied DNA copy number amplification mod-
els (V). Amplification patterns depict the 
ranges of the amplified areas and the gen-
eral structure of the amplicons.
Data mining of the DNA copy  
number amplifications (IV, V)
Data mining is a computational discipline 
for extracting meaningful knowledge from 
large data sets (Hand et al., 2001). In ad-
dition to the original quantitative measure-
ments and observations, data miners use 
metadata (data about the data or background 
data) to improve their inferences. Meaning-
fulness of the information is usually mea-
sured using statistical methods and explor-
ing the non-random dependencies in the 
data.
The amplification hot spots (IV) and am-
plification patterns (V) were fused with rele-
vant cytogenetic and genomic metadata and 
statistical hypothesis testing methods were 
applied to enlighten the elemental factors 
contributing to the mechanisms and the se-
lectivity of amplification. Chromosomal fea-
tures and genomic annotations were collect-
ed from the literature and databases. In gen-
eral, the frequencies of chromosomal and 
genomic features on amplification hot spots 
and amplification patterns were compared 
to a random reference. The significance of 
the differences in the frequencies was as-
sessed using a statistical hypothesis test and 
permutation analysis.
An inherent structure in the amplifica-
tion model-based clustering of cancer cases 
was compared to the clinicohistopatholog-
ical classification of cancers (V). The clas-
sification data were collected from World 
Health Organization (Kleihues and So-
bin, 2000 – 2006) and a data set of 101 at-
tributes and 29 different parameters from 
95 different neoplasms and 82 cancer types 
was compiled. A comparison of the propor-
tion of an attribute in a specific cluster to a 
random reference was used to test the accu-
mulation of specific attributes in individu-
al clusters. A statistical hypothesis test was 
used to measure the significance of the dif-
ference in the proportions and random per-
mutation analysis was applied to determine 
the empirical p-value.
Summary of the Methods (I – V)
The methods have been summarized in Fig-
ure 12. ❦
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Gene expression changes and regulatory 
networks in H. pylori infected cells
The pathogenesis of the H. pylori partly 
comes across via the host responses, and 
gene expression changes in the host cells 
are likely to contribute to the promotion of 
the malignant phenotype. Invitro model and 
DNA microarrays were used to screen the 
target genes of H.pylori in the host. H.pylori 
infection induced differential expression of 
several target genes. According to the time 
series experiments and microarray analysis, 
FOS was the primary target in the infection 
and was up-regulated after 30 min of co-cul-
ture (Table 1 in I). Furthermore, FOSL1 and 
ATF3 were rapidly up-regulated in H.pylo-
ri stimulated AGS cells (Table 1 in I). Many 
genes encoding heat shock (e.g., DNAJB1 
and HSPA1A) and DNA damage response 
proteins (e.g., GADD45A) were up-regulat-
ed by H.pylori infection (I). Heat shock pro-
teins are expressed when cells are exposed 
to stress. The transcription of GADD45A 
has been shown to increase when cells are 
exposed to DNA damaging agents in environmental stress, and to 
go to growth arrest (Jackman et al., 1994) and ATF3 protein level 
increases rapidly as a response to diverse stress conditions (Jiang et 
al., 2004). ATF3 expression has been shown to be associated with 
CagA positivity (Zhang et al., 2007).  The up-regulation of ATF3 
and GADD45A has been validated using a H.pylori infection mod-
el on the human gastric epithelial immortalized GES-1 cells (Liu et 
al., 2006). H.pylori regulated gene network functions in mecha-
nisms that are activated in response to cellular damage and stress.
Gene expression changes induced by H.pylori infection are reg-
ulated by the action of specific transcription factors. The modula-
tion of the transcription factor activity is the main mechanism by 
which H.pylori is able to hijack cellular functions and abuse the 
host. A gene expression profile data and a bioinformatics approach 
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were used to decipher the transcription fac-
tors that are activated after H.pylori stimu-
lation. Computational analysis revealed 16 
transcription factors that were significant-
ly (p<0.01) enriched in H.pylori regulated 
genes’ promoter regions (Table 1 in II). EMSA 
assay demonstrated that H.pylori stimula-
tion of AGS cells resulted in an increased 
activation of NF-κB transcription factor and 
p50 and p65 subunits in the 3 h time point 
(Figure 1 in II). Previously, the activation of 
FOS (Meyer-ter-Vehn et al., 2000), NF-κB 
(p50 and p65 subunits) (Maeda et al., 
2000), USF and CREB (Juttner et al., 
2003) transcription factors have been shown 
to associate with H.pylori infection. More-
over, transcription factors that have not been 
linked with H.pylori infection were identi-
fied (ARNT, ELF1, EPAS1, E2F, MAX, MYC, 
MYC-MAX, SNAI1, TBP, and TCF3). H.py-
lori activated transcription factors function 
in cellular processes that are associated with 
carcinogenesis. NF-κB and FOS function in 
the production of the pro-inflammatory cyto-
kines and in the activation of primary epithe-
lial innate immunity response to pathogens 
(Eferl and Wagner, 2003; Karin et al., 
2002) as well as the regulation of the anti-
apoptotic and proliferative signaling (Karin 
et al., 2002). MYC is involved in cell-cycle 
progression, it promotes cell proliferation 
and is also associated with cancer initia-
tion (Pelengaris et al., 2002). ARNT and 
CREB regulate cell response to hypoxia and 
promote angiogenesis (Harris, 2002). E2F 
controls cell-cycle and is associated with cell 
growth (Nevins, 2001). SNAI1 promotes tu-
morigenesis by repressing E-cadherin, in-
creasing cell motility and by promoting in-
vasive growth (Thiery, 2002). USF1/2 tran-
scription factors control telomerase reverse 
transcriptase (TERT) activity, which is re-
quired for immortalization and continu-
ous replication (Goueli and Janknecht, 
2003). The transcription factors of H.pylori 
response are involved in cancer-related cel-
lular mechanisms.  
In eukaryotic cells, transcription activi-
ty is controlled by the signal transduction 
pathways that consist of proteins that are 
sequentially activated so as to transfer sig-
nals from outside the cell into the nucle-
us, where response is executed at the level 
of gene expression. Cells have many recep-
tors that they use to monitor their surround-
ings. Some of these receptors are used to 
detect pathogens. For example, toll-like 
receptor 4 binds to lipopolysaccharide of 
H.pylori (Kawahara et al., 2001). In addi-
tion to the surveillance proteins of the host, 
pathogens have evolved proteins that mimic 
cellular signaling proteins and evoke phony 
cell responses. For instance, H.pylori secret-
ed cagA toxin interacts with the host cell’s 
signaling proteins (Atherton et al., 2001; 
Hatakeyama, 2004). Even when cross-talk 
between different signaling pathways might 
exist, both, pertinent physiological respons-
es to bacteria as well as H.pylori secreted 
disturbance signals are likely to contribute 
to specific pathway activation in H.pylori 
infected cells. Due to the fact that H.pylori 
strains that carry bacterial toxins are more 
carcinogenic, there might be specific path-
way targets for the toxins that are related to 
the progression of the malignancy. H.pylo-
ri activated transcription factors were used 
to chart the signal transduction pathways 
that were associated with the infection (II). 
H.pylori stimulation regulated transcription 
factors were shown to bind to specific tar-
get sequences and function as downstream 
targets of Ahr signal transduction pathway, 
MAPK signaling pathway, NF-κB signaling 
pathway, RB pathway, and Wnt signaling 
pathway (Table 1 in II). Additionally, using 
the information from Biocarta, a model 
explaining the gene regulatory network 
of H.pylori infection in a host cell could 
be drafted (Figure 2 in II). The activation 
of MAPK and NF-κB signal transduction 
pathways have been shown to occur after 58
H.pylori infection (Juttner et al., 2003; 
Kawahara et al., 2001; Maeda et al., 2000; 
Meyer-ter-Vehn et al., 2000; Mitsuno et 
al., 2001; Nakayama et al., 2004; Su et al., 
2003). NF-κB signaling is most likely acti-
vated through lipopolysaccharide sensing by 
Toll-like receptor 4 (Kawahara et al., 2001), 
whereas cagA and VacA toxins are taught to 
activate MAPK signaling (Atherton et al., 
2001; Hatakeyama, 2004). Apart from the 
known H.pylori regulated pathways, novel 
signal transduction pathways, namely Ahr, 
WNT and E2F, were identified. H. pylori 
pathogenecity probably acts through specific 
signaling pathways and the identification of 
cellular responses with malignant potential 
would serve as biomarkers for predicting 
the outcome of the infection.
H.pylori induced reactive changes in the 
host cell’s gene expression are not explicitly 
cancer-related; rather, these changes affect 
cellular mechanisms that have the poten-
tial to lead to perturbations that cause can-
cer. H.pylori stimulation activated NF-κB 
transcription factor, which is a key regula-
tor of inflammation and cancer promoting 
cellular mechanisms. Among others, 
H.pylori target genes and signal transduc-
tion pathways regulate cell-proliferation, 
apoptosis and cell motility. Increased cell 
turnover can lead to increased mutation rate 
and carcinogenesis. Similarly, failures in 
executing apoptosis in control may have 
cancer-promoting implications. Cell prolife-
ration involves DNA replication, which has 
a low but significant error rate, and H.pylori 
infection, which favors cell proliferation, is 
indirectly mutagenic. In the view of the fact 
that H.pylori infection regulated pathways 
that are constitutively active in gastritis and 
operate critical cellular functions, the genes 
encoding for proteins involved in these 
activities are likely targets for mutations. It 
could be further postulated that those path-
ways that are hijacked in H. pylori infec-
tion and the genes that they control might 
be preferential targets for genomic changes 
in gastric cancer initiation. H. pylori 
infection regulated genes in AGS cells were 
enriched in the chromosomal regions that are 
frequently implicated in gastric cancer (Table 
2 in I). The transcriptional activation of 
H. pylori infection target genes involves 
introducing changes in the chromatin struc-
ture. Histone coiling needs to be disassembled 
in order to get the transcription protein 
complex to access DNA. In open forma-
tion, the physical protection of chromatin 
reduces and DNA gets exposed to muta-
genic agents. DNA in the open chroma-
tin formation is more likely to be damaged 
than DNA in the inactive regions of the 
genome. All in all, H.pylori infection leads 
to activation of the cellular mechanisms that 
increase the probability of DNA damage, 
mutations and cancer promotion. 
Putative gastric cancer target genes
Biomarkers are measurable properties that 
can be used to indicate a biological char-
acteristic of the sample object. Genome-
wide microarray technologies are excel-
lent tools for screening the genome for 
anomalies that could indicate a malignancy 
state or a certain biological process that is 
involved in cancer. Microarrays were exploited 
to identify the putative biomarkers and the 
biologically relevant target genes in gastric 
cancer. Putative gastric cancer biomarker 
genes were identified by integrating the 
gene expression and the copy number 
microarray data (III). The rationale behind 
integrating the gene expression with the 
copy number is that those genes that are dif-
ferentially expressed due to a change in the 
copy number are more likely to be involved 
in cancer promoting processes. The integra-
tion of gene expression and copy number 
measurements revealed genes that were up-
regulated in association with copy number 
gain or down-regulated in association with 
copy number loss (Figure 2 and Table 1 in III). 
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The 17q12-q21 region contained many genes 
that were up-regulated in association with 
amplification (Figure 2 in III). Amplifica-
tion and expression of ERBB2 as well as 
of other genes in the 17q12-q21 region have 
previously been identified (Maqani et al., 
2006; Varis et al., 2004). In addition, 
several novel gastric cancer candidate genes 
were identified. These novel putative gas-
tric cancer biomarker genes provide a pri-
oritized selection of candidate genes for fur-
ther studies.
Gastric cancer is divided into two main 
histological subtypes, namely intestinal 
and diffuse, which have different clinical 
and biological features (Lauren, 1965). The 
information of the histology of the tumors 
was used in fusion with gene copy num-
ber profiling data in order to identify sub-
type specific changes. Intestinal type gas-
tric cancer was characterized by amplifica-
tion of ERBB2 and gains at 20q13 and Xp 
(III). Previously, 17q12-q21 amplifications 
have been linked to intestinal type gastric 
cancer (Kokkola et al., 1997; Maqani et 
al., 2006; Vauhkonen et al., 2006). More 
specifically, the ERBB2 gene was shown to 
be activated, in RNA (Figure 2 in III) and 
protein levels (Figure 3 in III), by an am-
plification in the intestinal type gastric can-
cer (III). ERBB2 is a transmembrane recep-
tor tyrosine kinase, which functions in cel-
lular signal transduction and regulates pro-
cesses that are frequently perturbed in can-
cer. There is a new category of cancer ther-
apies which target protein kinases. ERBB2 
amplification and overexpression have been 
proposed as a therapeutic biomarker in gas-
tric cancer and Trastuzumab (ERBB2 tyro-
sine kinase domain binding monoclonal 
antibody) treatment was shown to inhibit tu-
mor growth in gastric cancer cell lines and 
in a patient (Gong et al., 2004; Rebisc-
hung et al., 2005). According to amplifica-
tion modeling analysis, the 17q12-q21 region, 
which contains the ERBB2 gene, is ampli-
fied in gastric and esophageal adenocarci-
nomas (Figure 5A in V). 17q12-q21 amplifica-
tion was also typical for cancers of epithelial 
origin, more specifically adenocarcinomas. 
These data suggest that the 17q12-21 amplifi-
cations are specific for epithelial type cancer 
of the gastroesophageal tract and amplifica-
tion and over-expression of ERBB2 could be 
used as a biomarker for intestinal type gas-
tric cancer in the proximal stomach. 
There were interconnections between 
H.pylori infection regulated genes and gas-
tric cancer genome. MUC1 was shown to 
be amplified and over-expressed in intes-
tinal type gastric cancer (Figures 2 and 3 
in III). ERBB2 has been shown to phos-
phorylate MUC1 (Li et al., 2001; Schroe-
der et al., 2001) and regulate its interac-
tion with β-catenin (Yamamoto et al., 
1997). In conjunction, H. pylori binds to 
MUC1 on the surface of gastric epithelium 
(Vinall et al., 2002) and activates 
β-catenin in gastric epithelial cells (Franco 
et al., 2005). β-catenin has been shown to 
enhance invasiveness and promote prolifer-
ation in gastric cancer cell lines (Lowy et al., 
2006). Based on these observations, there 
are multiple mechanisms – gene copy num-
ber gain, ERBB2 kinase phosphorylation 
and H.pylori binding – that are capable of ac-
tivating MUC1. Furthermore, MUC1 might 
be involved in gastric carcinogenesis by pro-
moting proliferation and invasion through 
interaction with β-catenin. PPP1R1B was 
one of the target genes at 17q21.1 that was 
up-regulated by a copy number gain (Table 1 
and Figure 2 in III). PPP1R1B transcription 
was also up-regulated by H.pylori infection 
(Supplementary data in I). Because H.py-
lori infection and gene copy number gain 
are both potential activators of PPP1R1B that 
further strengthens its central role in gas-
tric carcinogenesis. Depending on the phos-
phorylation pattern of specific amino acid 
residues, PPP1R1B functions as a kinase or 
phosphatase inhibitor (Bibb et al., 1999; 60
Greengard et al., 1999). Based on its func-
tion, PPP1R1B is a potent regulator of cellu-
lar signal transduction that could promote 
carcinogenic processes in gastric cancer. 
Confluences in genomic functions of gas-
tric cancer and its premalignant condition, 
H.pylori infection, suggest that there is a 
connection between molecular pathways in 
the different steps of gastric carcinogenesis.
DNA copy number  
amplifications in cancer
DNA copy number amplifications were an-
alyzed from a large set of cancers to elu-
cidate the confluences and relationships 
between different cancer types. The cluster-
ing of neoplasms based on DNA copy num-
ber amplification frequency profiles showed 
that cancers with similar cell type or origin 
grouped together (Figures 1 and 2 in IV). 
For example, cancers of the gastrointesti-
nal tract, esophageal, gastric and colorectal 
adenocarcinomas, formed a tight cluster. 
Correspondingly, sarcomas (mesenchymal 
origin) of different anatomical locations 
clustered together. Carcinomas, epithelial 
cancers, formed separate cluster with a tight 
subcluster of squamous cell carcinomas that 
originate from columnar epithelium. Clus-
tering based on amplification frequencies 
suggests that the type of the cell-of-origin 
and/or tumor microenvironment deter-
mines the site specificity of DNA copy num-
ber amplifications. 
Amplification profiling analysis was not 
able to link specific cancer types with spe-
cific amplifications. DNA copy number am-
plification modeling and data fusing of can-
cer classification information were applied 
in order to study the background of the am-
plification-based clustering of human can-
cers (V). DNA copy number amplifications 
were modeled using finite mixtures of the 
Bernoulli Distributions (Figure 1 in V). Am-
plification models were used to cluster can-
cer cases (Figure 2 in V). Classification 
attributes (Figure 3 in V) and etiological fac-
tors (Figure 4 in V) were collected. Specific 
cancer types and classifications were shown 
to be associated with specific amplification 
models (Figure 5 in V). For example, 17q12-21 
amplification was associated with esoph-
ageal (Barret) and gastric adenocarcino-
mas (Figure 5A in V). In addition, 17q12-q21 
amplicon was over-represented in cancers 
that were related with tobacco, obesity, diet, 
bacteria, inflammation, gastrointestinal 
tract, esophagus, stomach, adenocarcinoma 
and epithelial background. It is noteworthy 
that the 17q12-21 amplification was identi-
fied in microarray analysis of gastric can-
cer (III). Molecular pathophysiology of can-
cer can be dissected by cell lineage-speci-
ficity (Garraway and Sellers, 2006). Cell 
lineage models presume that specific prop-
erties of the precursor stem cells promote 
the evolution of molecular changes in can-
cer. During embryonic development, epi-
thelial, hematological, mesenchymal and 
neuroepithelial cell-lineages emerge. The 
development of specific organs and tis-
sues unfolds through the differentiation 
of the specified stem cells. The amplifica-
tion spectrum in cancers seems to be deter-
mined by cell-lineage, seeing that specific 
amplifications were identified for different 
cell lineages of embryonic, tissue and organ 
development (IV and V). Site-specificity 
of amplifications in different cell lineages 
might reflect the properties of the cancer 
stem cells or of the selective microenviron-
ment in the tissue-of-origin. Oncogenes 
were shown to frequently map to amplifica-
tion target loci (Figure 13) (V).
In addition to the cell-lineage determina-
tion and the selection guided by oncogene 
attraction, genomic architecture is involved 
in the generation of amplifications. The 
structural outlines of amplicons depend 
on genomic properties that affect chromo-
somal durability and genomic integrity. The 
data mining of the amplification hot spots 61
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(IV) and maximal frequent itemsets of the 
amplification models (amplification pat-
terns) (V) revealed properties in the genomic 
architecture that were associated with mecha- 
nisms of DNA amplification. The mecha-
nistic models of amplification predict that 
DNA double-strand breaks initiate the am-
plification pathway. The statistical evidence 
showed that there are specific labile chromo- 
somal regions that are enriched in the mar-
gins of amplification patterns. Fragile sites, 
telomeres, light chromosome bands and 
centromeres were enriched at chromo-
somal sites that are often implicated in the 
breakpoints of amplicons. Large genes (in 
hundred kilobase range) were statistically 
significantly over-represented in the ampli-
fication hot spots. Correspondingly, fragile 
sites were preferentially co-localized with 
exceptionally large genes. Large genes may 
contribute to chromosomal fragility and 
promote amplicongenesis by increasing the 
probability of break-induction. One mecha-
nism that has been proposed to inflict chro-
mosomal breakage is the collision of tran-
scription and replication machineries. In 
plasmid reconstruction experiments, it has 
been shown that DNA double-strand breaks 62
Figure 13 
Amplification	models	and	co-localized	oncogenes	
30	most	frequently	observed	DNA	copy	number	amplification	patterns		
and	co-localized	cancer	genes.	Mode	was	extracted	from	the	amplification	
models	to	depict	the	most	probable	element	in	the	amplification	model.		
Cancer	genes	that	co-localize	with	the	mode	loci	were	collected	from	the		
CancerGenes	database	(higgins et al., 2007).
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occurred and amplification process was ini-
tiated by synchronized and site-directed 
transcription and replication (Shimizu et 
al., 2003). The transcription and replication 
of large genes considerably takes more time, 
which widens the window for an occasional 
collision between the two processes. Light 
chromosome bands contained multiple 
amplicon boundaries. Light chromosome 
bands are gene rich and usually in open 
conformation (Gilbert et al., 2004). The 
enrichment of amplification boundaries on 
light chromosome bands suggests that open 
chromatin would be more vulnerable and 
DNA damage prone than inactive closed 
chromatin. Telomeres were also among 
the chromosomal regions that were over- 
represented by amplification breakpoints. 
Telomere erosion in uncontrollably repli-
cating cancer cells is a mechanism that can 
produce DNA double-strand breaks in the 
telomere regions. Non-random distribution 
of labile genomic features indicated that the 
human genome is not evenly resilient, and 
that specific sites are more prone to DNA 
double-strand breaks. ❦

H. pylori activated the genes, transcription factors and sig-
nal transduction pathways that were identified in studies I and II. 
The molecular targets of H.pylori infection were associated with 
the cellular functions that might be capable of promoting carcino- 
genesis of the stomach. These targets could be useful when 
predicting the outcome of the infection and the designing novel treat-
ments. Intestinal and diffuse type gastric cancers showed distinct 
molecular genetic profiles and the integration of gene expression 
and copy number microarray data allowed the identification of genes 
that might be involved in gastric carcinogenesis and have clinical 
relevance (III). Even when some subtypes with concordant genomic 
changes were identified in gastric cancer, it is likely that most of the 
carcinomas of the stomach are unique diseases that do not share 
a specific genomic change. Gene amplifications were shown to be 
non-random genomic instabilities, and cell 
lineage, properties of precursor stem cells, tissue microenviron-
ment and genomic map localization of specific oncogenes to define 
the site specificity of DNA amplifications, whereas labile genomic 
features defined the structures of the amplicons (IV and V). These 
conclusions suggest that the definition of genomic changes in can-
cer is based on the interplay between cancer cell and the tumor 
microenvironment. Categorizing cancers according to their under- 
lying genetic properties, rather than looking at the appearance 
or behavior of the tumor, is likely to improve cancer treatment. 
Morphologically similar tumors may arise in the same anatomical 
location and still have entirely different genetic anomalies. 
Conversely, distinct genomic changes can cause cancers in different 
parts of the body as well as of diverse morphologies. Regardless of the 
site and behavior of the tumor, genetically coherent cancer subtypes 
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are likely to depend on the same molecular 
perturbations, and the understanding 
of the genetic underpinnings of cancers 
facilitates the development of the targeted 
treatments.
In the future, the identified putative bio-
markers for gastric cancer and H. pylori 
infection related carcinogenic processes need 
to be validated in a lager set of samples using 
alternative approaches and their roles in 
gastric cancer should be explored using 
functional experiments. Moreover, there 
might be a concordance among gastric 
cancers in higher hierarchy of genomic 
functionality, namely in the level of biologi-
cal processes and pathways, which could be 
revealed using a systems biology approach. In 
order to treat heterogeneous disease, such as 
gastric cancer, genomic properties of indivi-
dual tumors need to be decoded. Novel, high-
throughput, massively parallel sequencing 
technologies enable rapid and near genome- 
wide examination of the tumor DNA 
sequence, which is fundamental for the 
development of personalized treatments 
for gastric cancer. To fully understand the 
mechanisms and backgrounds of genomic 
changes, a large-scale datamining effort 
using DNA microarray or sequencing data 
should be executed. ❦
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Achlorhydric:
  A state when production of  
gastric acid in the stomach is low.
Adenocarcinoma:
  A type of cancer that originates  
from glandular epithelial tissue.
Amplicon:
  A genomic region  
containing multiple DNA copies.
Anaerobic organism:
  An organism that does  
not need oxygen to grow.
Anaphase:
  A late stage in cell division where  
sister chromatin moves towards oppo-
site poles of the dividing nucleus.
Antioxidant:
  A molecule that is capable of scaveng-
ing electrons and preventing oxidation 
of other molecules. Antioxidants  
protect cells from free radicals that are 
generated in oxidation reactions.  
Free radicals can damage cells.
Concepts Apoptosis:  A programmed cell death of  
a complex system of biological events 
leading to disposal of the cell.
Bernoulli distribution:
  A discrete probability distribution  
with two outcomes. Given outcome  
1 has a probability of p, outcome  
0 has a probability of p’ = 1-p.
Biomarker:
  An indicator of a specific  
biological state.
Carcinogenesis:
  A process where a normal cell  
is transformed into a cancer cell.
Centromere:
  A region of specific and repetitive  
DNA in the chromosomes that  
function in chromosomal segregation 
during cell division.
Chromatin:
  A composite of DNA and proteins 
forming the chromosome.
Confocal:
  An optic system that includes one  
lens for both focusing of the emission 
laser to the object and fluorescence  
to the image detector.
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Cross-validation:
  A procedure where data is divided  
into subsets, training and validation 
sets, that are used to executing  
the initial analysis and validating and 
conforming the result.
Data mining:
  “Analysis of large observational data 
sets to find unsuspected relationships 
and to summarize the data in novel 
ways that are both understandable and 
useful to the data owner.”  
(Hand et al., 2001)
DNA hybridization:
  A process of combining single- 
stranded complementary DNAs  
into one molecule.
DNA sequencing:
  A method of determining the order  
of the nucleotides in a DNA molecule.
Electrophoretic mobility shift assay:
  A laboratory technique that is used  
to study protein-DNA interactions.  
Proteins and radio-labeled DNA  
are mixed and radioactivity is detected 
using gel electrophoresis separation. 
Specific antibodies are used to  
identify proteins that bind to radio- 
labeled DNA.
Ensembl:
  A publicly available database  
for genomic information that can  
be accessed at www.ensembl.org.
Epidemiology:
  A discipline of studying factors  
that affect health and illnesses in  
populations.
Epigenetic:
  A change in the gene function without 
changing the basic structure of the un-
derlying DNA sequence. Epigenetic 
changes can remain after cell division.
Epithelial cell:
  In general, epithelial cells may  
originate from ectodermal (e.g., the 
epidermis), endodermal (e.g., the  
intestinal tract) and mesodermal  
(e.g. wall of gut) germ layers of the  
developing embryo. Epithelium is a 
classification of the tissue  forming 
glands and layers that line the cavities 
and structures of the body, for example 
skin, mouth, esophagus, gastroin- 
testinal tract as well as reproductive 
and urinary tracts. Cancers that origi-
nate from epithelium are called  
carcinomas.
Expection-Maximization algorithm:
  An iterative maximum likelihood  
estimation algorithm, to be used,  
for instance, in mixture models. 
Finite mixture model:
  In statistics and machine learning, a 
mixture model is a linear superposition 
of simple distributions (components), 
that together form a more complex  
distribution. Mixture models are used 
for example in clustering.
Forward selection algorithm:
  An algorithm that proceeds by  
combining the currently best set of  
variables with the remaining single  
variables and chooses the best combi-
nation as the new current best set.
Fusion gene:
  A combination of previously  
separate genes.
Gamete:
 A haploid egg and sperm cell.76
Gastric atrophy:
  Partial or complete disappearance  
of the gastric mucosa, glands and  
gastric pits.
Gastric ulcer:
  A gastric wound that derives  
from the necrotic tissue removal.
Gastritis:
  An inflammation of the mucous  
membrane layer of the stomach.
Genome:
  organism’s hereditary information  
encoded in DNA.
Glioma:
 A brain tumor arising from glial cells.
Hybridization probe:
  A fragment of DNA used to detect  
presence of complementary DNA or 
RNA in the sample.
Immunohistochemistry:
  A laboratory technique, which utilizes 
antibodies to detect specific antigens in 
tissues.
Intestinal metaplasia:
  A premalignant condition where gastric 
epithelium has been replaced with cells 
of intestinal morphology.
Kinase:
  An enzyme that catalyzes a reaction 
called phosphorylation, the transfer  
of a phosphate group from a donor 
molecule, e.g., ATP, to a target (sub-
strate). Protein kinases are modifying  
the function of target proteins by  
phosphorylation.
Lesion:
  A pathologic change in tissue  
structure and function.
Leukocyte:
  A cell of the immune system.  
white blood cells are specialized to 
neutralize microbe infections and  
foreign material. Leukocytes derive 
from hematopoietic stem cells in the 
bone marrow.
Machine learning:
  A computational discipline of  
identifying patterns and extracting 
rules from large data sets using  
statistical methods and algorithms  
that are able to learn from the data.
Massively parallel sequencing:
  A method that allows high-throughput  
DNA sequencing. The sequencing by 
extension platforms (Thomas et al., 
2006) from 454 Life Sciences  
(Bradford, CT) and Illumina (Hayward, 
CA) can sequence over 100 megabase 
s per day.
Maximum likelihood:
  A principle that estimates parameters 
to maximize the probability of the data.
Mesenchymal cell:
  A type of cell originating from the me-
sodermal germ layer of the developing 
embryo. Given a proper extracellular 
environment, the mesenchymal cells 
are able to migrate individually. This 
class of cells includes typically the cells 
in the connective tissue, bone, muscle  
and fat. Mesenchymal tumors arise 
from mesenchymal stem cells.
Metadata:
  Background data about the  
observational measurement data.
Metaphase:
  A stage in mitosis, in the eukaryotic  
cell cycle, in which chromosomes are 
condensed and aligned in the middle  
of the nucleous.77
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Concepts
Metaplasia:
  Replacement of the original  
differentiated cell type with another  
differentiated cell type.
Metastasis:
  Spreading of the malignant tumor cells 
from a primary anatomical location to 
another site that is not adjacent to the 
original location.
Monoclonal antibody:
  Antibodies, also called immunoglobu-
lins, are proteins that are produced by 
specialized immune system cells,  
B-cells. Antibodies bind to specific mi-
crobial structures, antigens, and initi-
ate the immune response to neutral-
ize the infection. Each cell produces a 
unique antibody and monoclonal an-
tibodies refer to proteins produced by 
one type of B-cell that has been clonally 
multiplied. Monoclonal antibodies are 
used in cancer therapy to neutralize de-
regulated oncoproteins.
Naïve Bayes classifier:
  A probabilistic classifier, which  
assumes, given the class variable,  
that the variables in the model  
are independent.
Neuroblastoma:
  The most common solid tumor  
in children arising from sympathetic 
nervous system.
Oncogenes:
  Class of genes that encode proteins 
that promote transformation of  
cells to cancer cells when mutations  
increase or dysregulate their activity.
Orthologous:
  Corresponding elements  
between two species.
Permutation analysis:
  A method of generating the empirical  
probability distribution by randomly  
mixing data. The obtained permuted  
probability distribution can be then 
used to estimate the significance of  
the true observation.
Promoter:
  A DNA region of specific sequence that 
is involved in controlling the expression 
of the adjacent gene by binding specific 
transcription factors.
P-value:
  Probability of obtaining a value  
by random that is at least as extreme  
as the measured value.
P-value correction:
  when multiple hypotheses are  
measured, some p-values may become 
significant by chance. There are differ-
ent methods that can be used to correct 
the p-values obtained from a statistical 
test repeated many times.
Real-time polymerase chain reaction:
  A technique that can be used to detect 
and quantify the amount of a specific 
DNA sequence in a sample. The proce-
dure follows basic PCR but the accumu-
lation of a PCR product is measured  
after each amplification cycle. when 
RNA is used as a template it has to be 
reverse transcribed into cDNA before 
quantitative PCR reaction.
Receiver operating characteristic:
  A curve depicting the trade-off between 
the false positives and true positives 
for a diagnostic system for every cut-off 
point for decision.
Somatic cells:
  All other cells in the body  
except the cells of the germ line.
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Stromal cells:
  Cells that form the supportive  
framework of connective tissue.
Systems biology:
  An approach to study the complex  
interactions between components  
of the biological system.
Telomere:
  A region of repetitive DNA in the  
ends of the chromosomes. Telomeres 
function, for example, in protecting 
chromosomes from breakage during 
replication and cell division.
Transcription factor:
  A protein that binds specific DNA  
sequence and is part of the protein 
complex that controls transcription.
T-test:
  A statistical test that is used to compare 
mean values in two groups of normally 
distributed random variables.
Tumor suppressor genes:
  A class of genes that encode proteins 
that function to prevent cells from 
transformation into cancer cells.
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